<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Nutr Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Nutr Sci</journal-id><journal-id journal-id-type="publisher-id">JNS</journal-id><journal-title-group><journal-title>Journal of Nutritional Science</journal-title></journal-title-group><issn pub-type="epub">2048-6790</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27313852</article-id><article-id pub-id-type="pmc">4791521</article-id><article-id pub-id-type="doi">10.1017/jns.2015.40</article-id><article-id pub-id-type="pii">S2048679015000403</article-id><article-id pub-id-type="publisher-id">00040</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Consumption of a high-fat meal containing cheese compared with a vegan
alternative lowers postprandial C-reactive protein in overweight and obese individuals
with metabolic abnormalities: a randomised controlled cross-over study</article-title><alt-title alt-title-type="left-running">Elieke Demmer <italic>et al.</italic></alt-title><alt-title alt-title-type="right-running">Consumption of a high-fat meal containing cheese
compared with a vegan alternative lowers postprandial C-reactive protein in overweight and
obese individuals with metabolic abnormalities</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Demmer</surname><given-names>Elieke</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Van Loan</surname><given-names>Marta D.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Rivera</surname><given-names>Nancy</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rogers</surname><given-names>Tara S.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gertz</surname><given-names>Erik R.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>German</surname><given-names>J. Bruce</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Zivkovic</surname><given-names>Angela M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Smilowitz</surname><given-names>Jennifer T.</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Nutrition</addr-line>,
<institution>University of California Davis</institution>, <addr-line>Davis,
CA</addr-line>, <country>USA</country></aff><aff id="aff2"><label>2</label><institution>USDA/ARS Western Human Nutrition Research
Center</institution>, <addr-line>Davis, CA</addr-line>, <country>USA</country></aff><aff id="aff3"><label>3</label><addr-line>Foods for Health Institute</addr-line>,
<institution>University of California</institution>, <addr-line>Davis, CA</addr-line>,
<country>USA</country></aff><aff id="aff4"><label>4</label><addr-line>Department of Food Science &#x00026;
Technology</addr-line>, <institution>University of California</institution>,
<addr-line>Davis, CA</addr-line>, <country>USA</country></aff><author-notes><corresp id="cor1"><label>*</label><addr-line>Corresponding author: J. T.
Smilowitz</addr-line>, fax <fax>+1 530 752 4759</fax>, email <email>jensm@ucdavis.edu</email></corresp></author-notes><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>9</day><month>2</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e9</elocation-id><history><date date-type="received"><day>18</day><month>7</month><year>2015</year></date><date date-type="rev-recd"><day>17</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>11</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article, distributed under the terms of the Creative
Commons Attribution licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits
unrestricted re-use, distribution, and reproduction in any medium, provided the original
work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S2048679015000403a.pdf"/><abstract abstract-type="normal"><p>Dietary recommendations suggest decreased consumption of SFA to minimise CVD risk;
however, not all foods rich in SFA are equivalent. To evaluate the effects of SFA in a
dairy food matrix, as Cheddar cheese, <italic>v</italic>. SFA from a vegan-alternative
test meal on postprandial inflammatory markers, a randomised controlled cross-over trial
was conducted in twenty overweight or obese adults with metabolic abnormalities.
Individuals consumed two isoenergetic high-fat mixed meals separated by a 1- to 2-week
washout period. Serum was collected at baseline, and at 1, 3 and 6 h postprandially and
analysed for inflammatory markers (IL-6, IL-8, IL-10, IL-17, IL-18, TNF&#x003b1;, monocyte
chemotactic protein-1 (MCP-1)), acute-phase proteins C-reactive protein (CRP) and serum
amyloid-A (SAA), cellular adhesion molecules and blood lipids, glucose and insulin.
Following both high-fat test meals, postprandial TAG concentrations rose steadily
(<italic>P</italic> &#x0003c; 0&#x000b7;05) without a decrease by 6 h. The incremental AUC (iAUC)
for CRP was significantly lower (<italic>P</italic> &#x0003c; 0&#x000b7;05) in response to the
cheese compared with the vegan-alternative test meal. A treatment effect was not observed
for any other inflammatory markers; however, for both test meals, multiple markers
significantly changed from baseline over the 6 h postprandial period (IL-6, IL-8, IL-18,
TNF&#x003b1;, MCP-1, SAA). Saturated fat in the form of a cheese matrix reduced the iAUC for CRP
compared with a vegan-alternative test meal during the postprandial 6 h period. The study
is registered at clinicaltrials.gov under NCT01803633.</p></abstract><kwd-group><title>Key words</title><kwd>Dairy products</kwd><kwd>Inflammation</kwd><kwd>Metabolic syndrome</kwd><kwd>Obesity</kwd><kwd>Palm oil</kwd><kwd>Postprandial metabolism</kwd><kwd>Vegan diets</kwd></kwd-group><kwd-group kwd-group-type="abbreviations"><title>Abbreviations</title><kwd>CH, cheese</kwd><kwd>CRP, C-reactive protein</kwd><kwd>HOMA-IR, homoeostasis model assessment of insulin resistance</kwd><kwd>iAUC, incremental AUC</kwd><kwd>MCP-1, monocyte chemotactic protein-1</kwd><kwd>SAA, serum amyloid-A</kwd><kwd>sICAM, soluble intracellular adhesion molecule</kwd><kwd>VA, vegan alternative</kwd><kwd>WC, waist circumference</kwd></kwd-group><counts><fig-count count="4"/><table-count count="4"/><ref-count count="66"/><page-count count="12"/></counts></article-meta></front><body><p>One independent risk factor for CVD is postprandial inflammation, or inflammation in the
hours immediately following a meal (for a review, see Burdge &#x00026; Calder<sup>(</sup><xref rid="ref1" ref-type="bibr">
<sup>1</sup>
</xref><sup>)</sup>). Consumption of a meal promotes a transient inflammatory response, the
intensity and duration of which is determined by the composition of the meal (for a review,
see Margioris<sup>(</sup><xref rid="ref2" ref-type="bibr">
<sup>2</sup>
</xref><sup>)</sup>). A high-fat meal increases TAG- rich lipoproteins, a phenomenon known as
postprandial lipaemia, which is linked to CVD risk<sup>(</sup><xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref><sup>)</sup>. Both postprandial inflammatory and lipaemic responses contribute to a
chronic pro-inflammatory state observed in metabolically abnormal individuals, termed
metabolic inflammation, which further exacerbates CVD risk (for a review, see
Margioris<sup>(</sup><xref rid="ref2" ref-type="bibr">
<sup>2</sup>
</xref><sup>)</sup>). Observational studies have linked saturated fat consumption with
increased risk for CVD development<sup>(</sup><xref rid="ref4" ref-type="bibr">
<sup>4</sup>
</xref><sup>,</sup><xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref><sup>)</sup>. The specific effects of varying fatty acid composition have been
investigated extensively, with the latest consensus purporting that MUFA and PUFA are
beneficial whereas SFA and <italic>trans</italic>-fats are deleterious in terms of plasma
lipid profiles and CVD risk (for a review, see Erkkil&#x000e4; <italic>et
al.</italic><sup>(</sup><xref rid="ref6" ref-type="bibr">
<sup>6</sup>
</xref><sup>)</sup>). Decreasing SFA intake has been the cornerstone of dietary recommendation
for several decades, including the current Dietary Guidelines for Americans
2010<sup>(</sup><xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref><sup>)</sup>. However, decreasing SFA intake may not lower CVD risk in a subset of the
population<sup>(</sup><xref rid="ref8" ref-type="bibr">
<sup>8</sup>
</xref><sup>)</sup>. In fact, a recent meta-analysis of twenty-two prospective studies found
that consumption of certain dairy foods that are high in SFA, specifically cheese, was found
to be inversely associated with CVD risk<sup>(</sup><xref rid="ref9" ref-type="bibr">
<sup>9</sup>
</xref><sup>)</sup>. The postprandial effect of dairy foods is more than the sum of its parts.
When analysed individually, dairy-derived proteins<sup>(</sup><xref rid="ref10" ref-type="bibr">
<sup>10</sup>
</xref><sup>)</sup>, SCFA<sup>(</sup><xref rid="ref11" ref-type="bibr">
<sup>11</sup>
</xref><sup>)</sup>, bacteria in fermented dairy products (for a review, see Settanni
&#x00026; Moschetti<sup>(</sup><xref rid="ref12" ref-type="bibr">
<sup>12</sup>
</xref><sup>)</sup>), and milk fat globule membrane<sup>(</sup><xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref><sup>)</sup>, have shown favourable or neutral effects on CVD risk. However, little is
known about the combination of components in cheese and their interactions, known as the food
matrix (for a review, see Jacobs <italic>et al.</italic><sup>(</sup><xref rid="ref14" ref-type="bibr">
<sup>14</sup>
</xref><sup>)</sup>), on postprandial lipaemia and inflammation. The majority of studies
examining postprandial inflammation in response to high-fat dietary challenges compared SFA
with MUFA and PUFA, but not with other high-SFA foods that varied in fatty acid
composition<sup>(</sup><xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref><sup>,</sup><xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref><sup>)</sup>. Additionally, the consumption of SFA from dairy products in the context
of a complex matrix such as cheese rather than as just milk, cream or butter have not been
examined. This is surprising considering that cheese is the primary source of SFA in the
American diet<sup>(</sup><xref rid="ref17" ref-type="bibr">
<sup>17</sup>
</xref><sup>)</sup>. A recent study documented that approximately 5&#x000a0;% of US adults are
vegetarian, of whom about half are vegan<sup>(</sup><xref rid="ref18" ref-type="bibr">
<sup>18</sup>
</xref><sup>)</sup>. These numbers have doubled from 2009 to 2011. The Dietary Guidelines
Advisory Committee recently noted that a diet higher in plant-based foods is more health
promoting than the current US diet<sup>(</sup><xref rid="ref19" ref-type="bibr">
<sup>19</sup>
</xref><sup>)</sup>. This is echoed in a position paper from the Academy of Nutrition and
Dietetics reporting that appropriately planned plant-based diets may help prevent and treat
certain chronic diseases<sup>(</sup><xref rid="ref20" ref-type="bibr">
<sup>20</sup>
</xref><sup>)</sup>. While there is research supporting a plant-based diet for optimal health,
this type of dietary pattern can still include plant-based saturated fats, such as palm oil.
Yet the postprandial effects of high-fat meals containing SFA from plant sources (i.e. palm
oil) have not been examined in human subjects. In mice, consumption of a diet enriched with
palm oil induced the highest levels of inflammation compared with other lipids tested,
including milk fat<sup>(</sup><xref rid="ref21" ref-type="bibr">
<sup>21</sup>
</xref><sup>)</sup>. Given the increasing interest in plant-based diets by the public, this
study set out to address the gap in knowledge about the effects of dietary saturated fat from
plant sources <italic>v</italic>. from dairy sources on postprandial inflammation.
Specifically, the aim of this study was to determine the effects of consuming two mixed
isoenergetic meals high in SFA from cheese compared with a non-dairy cheese alternative plus
palm oil on postprandial inflammatory and metabolic markers. We hypothesised that consumption
of a meal high in SFA from Cheddar cheese in overweight and obese individuals with metabolic
abnormalities would result in lower circulating pro-inflammatory markers in the postprandial
state compared with a meal with equal amounts of SFA from palm oil plus a non-dairy cheese
substitute.</p><sec sec-type="methods" id="sec1"><title>Methods</title><sec id="sec1-1" sec-type="subjects"><title>Participants</title><p>A total of twenty adults (seven men and thirteen women) were recruited. Inclusion
criteria were: age 18&#x02013;65 years, and either a BMI between 25 and 29&#x000b7;9&#x000a0;kg/m<sup>2</sup> plus
two traits of the metabolic syndrome defined by the American Heart Association as waist
circumference (WC)&#x000a0;&#x0003e;&#x000a0;40 inches (&#x0003e;102 cm) for men and 35 inches (&#x0003e;89
cm) for women, fasting plasma TAG&#x000a0;&#x02265;&#x000a0;150&#x000a0;mg/dl (&#x02265;&#x000a0;1.69 mmol/l), fasting plasma
HDL-cholesterol &#x0003c;40&#x000a0;mg/dl (&#x0003c;1.03 mmol/l) for men and &#x0003c;50&#x000a0;mg/dl
(&#x0003c;1.29 mmol/l) for women, blood pressure &#x02265;130/85&#x000a0;mmHg, and fasting glucose
&#x02265;100&#x000a0;mg/dl (&#x02265;5.6 mmol/l)<sup>(</sup><xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref><sup>)</sup>, or obese (BMI between 30 and 39&#x000b7;9&#x000a0;kg/m<sup>2</sup>). Participants&#x02019;
insulin sensitivity was determined from their fasting plasma glucose and insulin using the
homoeostasis model assessment of insulin resistance (HOMA-IR) with 2&#x000b7;6 or greater as a
cut-off point of insulin resistance<sup>(</sup><xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref><sup>)</sup>. Participants&#x02019; inflammation status was determined with the measurement
of fasting circulating CRP concentrations at 3&#x000a0;mg/l or above as associated with increased
CVD risk<sup>(</sup><xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref><sup>)</sup>. Exclusion criteria included immune-related diseases, gastrointestinal
disorders, cancer, type 2 diabetes, use of over-the-counter anti-obesity agents or
corticoid steroid within the last 12 weeks, daily use of anti-inflammatory pain
medication, self-reported eating disorder, poor vein assessment determined by the
phlebotomist, known allergy or intolerance to study food, vegetarian, consume &#x0003e;1
serving of fish per week, &#x0003e;14&#x000a0;g of fibre per 1000&#x000a0;kcal (4184 kJ)/d, &#x0003c;16:1 of
total dietary <italic>n</italic>-6:<italic>n</italic>-3 ratio, &#x0003e;1&#x000a0;% of daily energy
as <italic>trans</italic>-fats, initiation of fish, krill, flax, borage or primrose seed
oils within the last 12 weeks, dietary supplements of concentrated soya isoflavones,
resveratrol, other polyphenols, initiation of statin therapy within the last 12 weeks,
&#x0003e;10&#x000a0;% weight loss or gain during the past 6 months, initiation of an exercise
programme in the last month, plan to become pregnant in the next 6 months, pregnancy or
lactation, recent initiation, change, or cessation of hormonal birth control within the
last 12 weeks, and use of tobacco products. To establish fulfillment of the enrolment
criteria subjects completed a questionnaire regarding their health history, diet and
medication, completed an online FFQ, provided a fasting blood sample for analysis of blood
lipids and glucose, and were assessed for weight, height and WC at the screening visit.</p><p>The Institutional Review Board of the University of California at Davis approved the
study protocol, and all participants gave written informed consent prior to starting the
study. The study is registered at clinicaltrials.gov under NCT01803633.</p></sec><sec id="sec1-2"><title>Study design</title><p>A randomised, cross-over design was used in which investigators were blind to treatment
order. All participants received both treatments. To avoid any interaction effects a 1- to
2-week washout period was observed between treatments. Treatment order was randomly
assigned using a random allocation sequence generator (randomization.com; seed# 4234)
(<xref ref-type="fig" rid="fig01">Fig. 1</xref>). <fig id="fig01" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p>Enrolment and follow up of participants in the randomised cross-over trial. CH,
Cheddar cheese treatment; VA, vegan-alternative treatment.</p></caption><graphic xlink:href="S2048679015000403_fig1"/></fig></p><p>Volunteers were instructed to avoid alcohol consumption, non-steroidal inflammatory drug
use, and any anti-inflammatory supplements such as fish, krill, flax, borage or primrose
seed oils 72&#x000a0;h prior to each test day. Volunteers were instructed to avoid seafood, and
were asked to record everything they consumed 24&#x000a0;h before the test day, not to exercise,
and not to consume anything past 20.00 hours. We analysed the 1-d dietary records using
the Nutrition Data System for Research (NDSR; University of Minnesota) to ensure that
participants complied with pre-study dietary instructions.</p><p>After a 10&#x02013;12&#x000a0;h fast participants arrived at the Western Human Nutrition Research Center.
Upon arrival volunteers turned in their 1-d food record, filled out a modified
gastrointestinal questionnaire<sup>(</sup><xref rid="ref25" ref-type="bibr">
<sup>25</sup>
</xref><sup>)</sup>, provided a urine sample and fasted blood draw via venepuncture.
Measurements for blood pressure, heart rate, weight and WC were taken. Participants then
consumed the high-fat breakfast challenge within 20&#x000a0;min. Postprandial blood draws and
urine samples were collected at 1, 3 and 6&#x000a0;h. These time points were chosen based on
previous studies demonstrating peak cytokine concentrations observed 3 or 6&#x000a0;h after a
high-fat meal challenge<sup>(</sup><xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref><sup>)</sup> and oxylipins and eicosanoids change at 1 and 6&#x000a0;h from
baseline<sup>(</sup><xref rid="ref26" ref-type="bibr">
<sup>26</sup>
</xref><sup>,</sup><xref rid="ref27" ref-type="bibr">
<sup>27</sup>
</xref><sup>)</sup>.</p><p>Throughout the test day participants were not allowed to consume any food, but could
drink bottled water <italic>ad libitum</italic>. Participants either stayed at the
research centre or left between blood draws to attend classes or return to work. To
minimise physical activity, if participants left the research facility they did so by car,
not by foot or bicycle, and returned approximately 15&#x000a0;min and rested for 10&#x000a0;min prior to
the next blood draw.</p></sec><sec id="sec1-3"><title>Dietary challenges</title><p>The dietary challenges consisted of grilled sandwiches served with a blended beverage.
The cheese (CH) test meal consisted of medium Cheddar cheese (Tillamook Medium Cheddar
Cheese) while the vegan alternative (VA) consisted of Daiya Cheddar cheese (Daiya). Both
sandwiches were made with 100&#x000a0;% Whole Wheat Sandwich Thins (Oroweat). Each meal was paired
with a blended beverage to allow for the matching of energy, total fat, carbohydrates and
protein (Supplementary Table S1).</p><p>Each of the two meal challenges provided 40&#x000a0;% of the participant's total energy intake.
Energy intake was determined by using the National Academy of Sciences equation from the
Institute of Medicine Dietary Reference Intake that takes physical activity into account
in addition to sex, age, weight and height<sup>(</sup><xref rid="ref28" ref-type="bibr">
<sup>28</sup>
</xref><sup>)</sup>. Physical activity was determined using the Baecke Physical Activity
questionnaire, which assesses habitual physical activity and identifies three components
of physical activity: work, sport and leisure time excluding sport<sup>(</sup><xref rid="ref29" ref-type="bibr">
<sup>29</sup>
</xref><sup>)</sup>.</p><p>Each meal consisted of about 50&#x000a0;% fat, about 40&#x000a0;% carbohydrates, and about 10&#x000a0;% protein
and delivered between 45 and 75&#x000a0;g of fat depending on the individual's energy intake. The
Cheddar cheese provided 44&#x000a0;% of the fat in the CH meal and palm oil provided 38&#x000a0;% of the
fat in the non-dairy cheese substitute meal. The meals were isoenergetic, had the same
macronutrient composition as well as similar MUFA, PUFA and SFA composition (<xref ref-type="table" rid="tab01">Table 1</xref>). The only difference between the test meals
was individual fatty acid composition, the matrix in which it was delivered, dietary
cholesterol and Ca concentrations. Participants were instructed to eat everything on their
plate and rinse their blended beverage cup with water, then drink the rinse water.
<table-wrap id="tab01" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Nutrient composition of the test meals<xref ref-type="table-fn" rid="tfn1_2">&#x02020;</xref> (Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S2048679015000403_tab1"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">CH meal</th><th align="center" colspan="2" rowspan="1">VA meal</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Energy (kcal)</td><td rowspan="1" colspan="1">1002&#x000b7;9</td><td rowspan="1" colspan="1">114&#x000b7;5</td><td rowspan="1" colspan="1">1002&#x000b7;1</td><td rowspan="1" colspan="1">113&#x000b7;9</td></tr><tr><td rowspan="1" colspan="1">Energy (kJ)</td><td rowspan="1" colspan="1">4196&#x000b7;0</td><td rowspan="1" colspan="1">478&#x000b7;8</td><td rowspan="1" colspan="1">4192&#x000b7;6</td><td rowspan="1" colspan="1">476&#x000b7;3</td></tr><tr><td rowspan="1" colspan="1">Total carbohydrate</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">g</td><td rowspan="1" colspan="1">103&#x000b7;7</td><td rowspan="1" colspan="1">11&#x000b7;8</td><td rowspan="1" colspan="1">105&#x000b7;0</td><td rowspan="1" colspan="1">11&#x000b7;9</td></tr><tr><td rowspan="1" colspan="1">% total energy</td><td rowspan="1" colspan="1">39&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">39&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">Total protein</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">g</td><td rowspan="1" colspan="1">27&#x000b7;8</td><td rowspan="1" colspan="1">3&#x000b7;2</td><td rowspan="1" colspan="1">28&#x000b7;8</td><td rowspan="1" colspan="1">3&#x000b7;3</td></tr><tr><td rowspan="1" colspan="1">% total energy</td><td rowspan="1" colspan="1">11&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">10&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">Total fat</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">g</td><td rowspan="1" colspan="1">56&#x000b7;6</td><td rowspan="1" colspan="1">6&#x000b7;5</td><td rowspan="1" colspan="1">57&#x000b7;9</td><td rowspan="1" colspan="1">6&#x000b7;6</td></tr><tr><td rowspan="1" colspan="1">% total energy</td><td rowspan="1" colspan="1">49&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">50&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">Total SFA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">g</td><td rowspan="1" colspan="1">19&#x000b7;2</td><td rowspan="1" colspan="1">2&#x000b7;2</td><td rowspan="1" colspan="1">19&#x000b7;7</td><td rowspan="1" colspan="1">2&#x000b7;2</td></tr><tr><td rowspan="1" colspan="1">% total energy</td><td rowspan="1" colspan="1">16&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">17&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">Total MUFA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">g</td><td rowspan="1" colspan="1">21&#x000b7;1</td><td rowspan="1" colspan="1">2&#x000b7;4</td><td rowspan="1" colspan="1">21&#x000b7;7</td><td rowspan="1" colspan="1">2&#x000b7;5</td></tr><tr><td rowspan="1" colspan="1">% total energy</td><td rowspan="1" colspan="1">18&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">19&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">Total PUFA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">g</td><td rowspan="1" colspan="1">13&#x000b7;4</td><td rowspan="1" colspan="1">1&#x000b7;5</td><td rowspan="1" colspan="1">13&#x000b7;8</td><td rowspan="1" colspan="1">1&#x000b7;6</td></tr><tr><td rowspan="1" colspan="1">% total energy</td><td rowspan="1" colspan="1">11&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">12&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">SFA 4 : 0 (butyric acid) (%)***</td><td rowspan="1" colspan="1">1&#x000b7;4</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">SFA 6 : 0 (caproic acid) (%)***</td><td rowspan="1" colspan="1">0&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">SFA 8 : 0 (caprylic acid) (%)***</td><td rowspan="1" colspan="1">0&#x000b7;4</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">SFA 10 : 0 (capric acid) (%)</td><td rowspan="1" colspan="1">0&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">SFA 12 : 0 (lauric acid) (%)***</td><td rowspan="1" colspan="1">0&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">5&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">SFA 14 : 0 (myristic acid) (%)***</td><td rowspan="1" colspan="1">4&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">2&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">SFA 16 : 0 (palmitic acid) (%)***</td><td rowspan="1" colspan="1">16&#x000b7;10</td><td rowspan="1" colspan="1">0&#x000b7;01</td><td rowspan="1" colspan="1">20&#x000b7;24</td><td rowspan="1" colspan="1">0&#x000b7;02</td></tr><tr><td rowspan="1" colspan="1">SFA 18 : 0 (stearic acid) (%)***</td><td rowspan="1" colspan="1">7&#x000b7;71</td><td rowspan="1" colspan="1">0&#x000b7;00</td><td rowspan="1" colspan="1">3&#x000b7;28</td><td rowspan="1" colspan="1">0&#x000b7;00</td></tr><tr><td rowspan="1" colspan="1">SFA 20 : 0 (arachidic acid) (%)***</td><td rowspan="1" colspan="1">0&#x000b7;00</td><td rowspan="1" colspan="1">0&#x000b7;00</td><td rowspan="1" colspan="1">0&#x000b7;12</td><td rowspan="1" colspan="1">0&#x000b7;00</td></tr><tr><td rowspan="1" colspan="1">SFA 22 : 0 (behenic acid) (%)***</td><td rowspan="1" colspan="1">0&#x000b7;22</td><td rowspan="1" colspan="1">0&#x000b7;00</td><td rowspan="1" colspan="1">0&#x000b7;15</td><td rowspan="1" colspan="1">0&#x000b7;00</td></tr><tr><td rowspan="1" colspan="1">MUFA 16 : 1 (palmitoleic acid) (%)***</td><td rowspan="1" colspan="1">1&#x000b7;50</td><td rowspan="1" colspan="1">0&#x000b7;00</td><td rowspan="1" colspan="1">0&#x000b7;39</td><td rowspan="1" colspan="1">0&#x000b7;00</td></tr><tr><td rowspan="1" colspan="1">MUFA 18 : 1 (oleic acid) (%)*</td><td rowspan="1" colspan="1">34&#x000b7;97</td><td rowspan="1" colspan="1">0&#x000b7;02</td><td rowspan="1" colspan="1">36&#x000b7;78</td><td rowspan="1" colspan="1">0&#x000b7;01</td></tr><tr><td rowspan="1" colspan="1">MUFA 20 : 1 (gadoleic acid) (%)***</td><td rowspan="1" colspan="1">0&#x000b7;22</td><td rowspan="1" colspan="1">0&#x000b7;00</td><td rowspan="1" colspan="1">0&#x000b7;37</td><td rowspan="1" colspan="1">0&#x000b7;00</td></tr><tr><td rowspan="1" colspan="1">PUFA 18 : 2 (linoleic acid) (%)</td><td rowspan="1" colspan="1">22&#x000b7;98</td><td rowspan="1" colspan="1">0&#x000b7;02</td><td rowspan="1" colspan="1">21&#x000b7;80</td><td rowspan="1" colspan="1">0&#x000b7;02</td></tr><tr><td rowspan="1" colspan="1">PUFA 18 : 3 (linolenic acid) (%)***</td><td rowspan="1" colspan="1">0&#x000b7;72</td><td rowspan="1" colspan="1">0&#x000b7;00</td><td rowspan="1" colspan="1">1&#x000b7;94</td><td rowspan="1" colspan="1">0&#x000b7;00</td></tr><tr><td rowspan="1" colspan="1">Cholesterol (mg)<italic>***</italic></td><td rowspan="1" colspan="1">79&#x000b7;20</td><td rowspan="1" colspan="1">9&#x000b7;01</td><td rowspan="1" colspan="1">0&#x000b7;00</td><td rowspan="1" colspan="1">0&#x000b7;00</td></tr><tr><td rowspan="1" colspan="1">Total dietary fibre (g)***</td><td rowspan="1" colspan="1">12&#x000b7;27</td><td rowspan="1" colspan="1">1&#x000b7;39</td><td rowspan="1" colspan="1">15&#x000b7;60</td><td rowspan="1" colspan="1">1&#x000b7;77</td></tr><tr><td rowspan="1" colspan="1">Ca (mg)***</td><td rowspan="1" colspan="1">487&#x000b7;11</td><td rowspan="1" colspan="1">55&#x000b7;38</td><td rowspan="1" colspan="1">129&#x000b7;71</td><td rowspan="1" colspan="1">14&#x000b7;75</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>CH, cheese; VA, vegan alternative.</p></fn><fn><p>Significant difference between the two meals: *<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05,
**<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;005, ***<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;0005.</p></fn><fn id="tfn1_2"><label>&#x02020;</label><p>Comparison of the two dietary challenges. Nutrient composition was obtained using
Nutrition Data System for Research (NDSR). Test meals were based on total energy
expenditure thus values shown are average of all test meals (<italic>n</italic>
20).</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec1-4"><title>Blood analyses</title><p>Whole blood was collected at the Western Human Nutrition Research Center by a trained
phlebotomist for each time point. Whole blood was centrifuged in a tabletop
ultracentrifuge for 10&#x000a0;min at 4&#x000b0;C at 1300&#x000a0;<bold><italic>g</italic></bold> within 30&#x000a0;min of collection. Plasma was immediately separated into 1&#x000b7;5&#x000a0;ml
aliquots, and immediately frozen at &#x02013;70&#x000b0;C until analysis. Serum was isolated and
transferred into 1&#x000b7;5&#x000a0;ml aliquots after clotting for 30&#x000a0;min on ice and centrifugation and
immediately frozen at &#x02013;70&#x000b0;C until analysed.</p></sec><sec id="sec1-5"><title>Inflammatory markers</title><p>Serum collected at 0, 1, 3 and 6&#x000a0;h was used to analyse cytokines (IL-10, IL-17, IL-1&#x003b2;,
IL-2, IL-6, IL-8, monocyte chemotactic protein-1 (MCP-1), TNF&#x003b1;), as well as the
acute-phase proteins (C-reactive protein (CRP), serum amyloid-A (SAA)), and vascular
injury molecules soluble intracellular adhesion molecule (sICAM) and soluble vascular
adhesion molecule. Plasma was used to measure IL-18 concentrations. Analysis of all
inflammatory markers was completed using an electro-chemiluminescence detection system
using multiarray technology (SECTOR Imager 2400; Meso Scale Discovery) according to the
manufacturer's instructions. In brief, this system uses multi-array ninety-six-well plates
with multi-electrodes per well. Each electrode has a different capture antibody, allowing
for the analysis of multiple markers of interest at once. The assay procedure is similar
to that of a classic sandwich ELISA. A small amount of sample (25&#x02013;50&#x000a0;&#x000b5;l) serum or plasma
is added to each well. The markers of interest bind to the pre-coated capture antibodies.
To complete the &#x02018;sandwich&#x02019; a detection antibody that is conjugated with a label is added
and binds to the analyte. Finally the addition of a read buffer allows for the activation
of the label on the detection antibody, resulting in illumination after electrochemical
stimulation via voltage that runs through the plate in the reader. The instrument measures
the intensity of the light to quantify a measure of each analyte.</p></sec><sec id="sec1-6"><title>Metabolic parameters</title><p>Plasma glucose, insulin and a lipid panel including TAG, total cholesterol,
HDL-cholesterol, LDL-cholesterol, HDL:LDL ratio and non-HDL-cholesterol were assessed by
the clinical laboratory at the University of California Medical Center (Sacramento, CA) at
baseline and at 1, 3 and 6&#x000a0;h after consuming the high-fat challenge meal.</p></sec><sec id="sec1-7"><title>Clinical characteristics</title><p>Anthropometric data were collected at the screening visit and each test day visit.
Measurements included body weight (6002 Wheelchair Scale; Scale-tronix), WC (QM2000
Measure Mate; QuickMedical), height (Ayrton Stadiometer Model S100; Ayrton Corporation),
blood pressure and resting heart rate (Carescape V100 with Critikon Dura-cuf for either
adults or large adults; GE Medical Instruments). BMI was calculated as
kg/m<sup>2</sup>.</p></sec><sec id="sec1-8"><title>Statistical analysis</title><p>This study was a 2&#x000a0;&#x000d7;&#x000a0;4 factorial design: two treatments x four time points. Sample size
was calculated based on our primary outcome marker using the means and standard deviations
for IL-6 from a similar human study with overweight volunteers<sup>(</sup><xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref><sup>)</sup>. A secondary analysis was also conducted on other pro-inflammatory
cytokines, acute-phase proteins and vascular adhesion molecules based on previous research
that showed changes in these markers in healthy participants in response to high-fat test
meals containing similar amounts of fat as used in our study (for a review, see Herieka
&#x00026; Erridge<sup>(</sup><xref rid="ref30" ref-type="bibr">
<sup>30</sup>
</xref><sup>)</sup>).</p><p>To ensure that our sample size reflected the number of subjects needed to be 95&#x000a0;%
confident of our results, with 80&#x000a0;% power we needed eighteen volunteers. To account for
attrition 10&#x000a0;% was added for a final sample size of twenty. All data were checked for
normality visually with histograms and Q-Q plots as well as numerically with the
Shapiro&#x02013;Wilk test. Data were transformed as needed prior to conducting statistical
analysis. For cytokines with &#x0003c;10&#x000a0;% of samples below the detection limit (IL-17
only) the value recorded was the lowest limit of detection provided by the manufacturer
and divided by 10. For dependent variables with &#x0003e;10&#x000a0;% of the data below the
detection limit these markers were excluded from statistical analysis (IL-1&#x003b2; and IL-2).</p><p>Dietary data between treatments were compared using a paired two-tailed
<italic>t</italic> test. Differences in baseline concentration between treatments were
tested using a paired sample two-tailed <italic>t</italic> test. A mixed linear model was
conducted with treatment and time as fixed factors, subjects as the random effect and
treatment&#x000a0;&#x000d7;&#x000a0;time as the interaction term. If time was significant, multiple comparison
<italic>post hoc</italic> analysis with Bonferroni correction was carried out to compare
the concentrations at 0 <italic>v</italic>. 1&#x000a0;h, 0 <italic>v</italic>. 3&#x000a0;h, 0
<italic>v</italic>. 6&#x000a0;h, 1 <italic>v</italic>. 3&#x000a0;h, 1 <italic>v</italic>. 6&#x000a0;h, and 3
<italic>v</italic>. 6&#x000a0;h.</p><p>The incremental AUC (iAUC, area above baseline) and decremental AUC (area below baseline)
using the conventional trapezoid method were used to compare postprandial responses
between groups (response to test meals)<sup>(</sup><xref rid="ref31" ref-type="bibr">
<sup>31</sup>
</xref><sup>)</sup>. The iAUC was chosen over the total AUC because it reflects the
postprandial rise of metabolite concentrations above the non-zero fasting
value<sup>(</sup><xref rid="ref32" ref-type="bibr">
<sup>32</sup>
</xref><sup>)</sup>. iAUC between CH and VA groups were compared via paired
<italic>t</italic> tests and ANCOVA with subject as the random variable, treatment as the
fixed factor and baseline CRP concentrations as the covariate.</p><p>We conducted secondary analyses to determine if pre-existing clinical conditions affected
the inflammatory response to the high-fat meal challenge. We coded subjects for high
<italic>v</italic>. low baseline CRP levels known to be associated with increased
vascular risk (&#x0003c;3&#x000a0;mg/l, <italic>n</italic> 10; or
<underline>&#x0003e;</underline>3&#x000a0;mg/l, <italic>n</italic> 10). ANCOVA was used to identify
statistically significant differences in postprandial inflammatory markers between
treatments using baseline values of CRP as the covariate.</p><p>Differences were considered significant at <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05. Statistical
analyses were performed using SPSS version 20.0 software for Macintosh (SPSS).</p></sec></sec><sec sec-type="results" id="sec2"><title>Results</title><sec id="sec2-1"><title>Subject characteristics</title><p>A total of seventy-six participants underwent screening. As shown in <xref ref-type="fig" rid="fig01">Fig. 1</xref>, twenty subjects were randomly assigned to one of two
treatment groups in a cross-over design: CH (<italic>n</italic> 20) and VA
(<italic>n</italic> 20). After a 1- to 2-week washout period each subject crossed over to
the remaining treatment. All subjects completed both treatment arms with no attrition.</p><p>The baseline characteristics of the subjects are shown in <xref ref-type="table" rid="tab02">Table 2</xref> and metabolic characteristics of each participant are found
in Supplementary Table S2. Our study population was predominantly female (65&#x000a0;%) and
Caucasian (75&#x000a0;%). With respect to the metabolic syndrome, six of the twenty participants
had the metabolic syndrome with three or more of the five diagnostic traits, seven
participants had two of the five traits, and seven participants had only one trait. When
assessing their metabolic and inflammatory status, fourteen of the twenty participants
were considered insulin resistant with a HOMA-IR &#x0003e;2&#x000b7;6; ten of the twenty
participants had a high baseline CRP concentration
(<underline>&#x0003e;</underline>3&#x000a0;mg/l); and six of the twenty participants had both a
HOMA-IR &#x0003e;2&#x000b7;6 and baseline CRP concentration above 3&#x000a0;mg/l. Additionally, thirteen of
the twenty participants had a BMI of 30&#x000a0;kg/m<sup>2</sup> or greater and were abdominally
obese (WC &#x0003e;35 inches (&#x0003e;89 cm) for women and &#x0003e;40 inches (&#x0003e;102
cm) for men). <table-wrap id="tab02" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Subject baseline characteristics<xref ref-type="table-fn" rid="tfn2_2">*</xref>
(Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S2048679015000403_tab2"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="center" width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">MetS criteria<xref ref-type="table-fn" rid="tfn2_3">&#x02020;</xref></th><th align="center" rowspan="1" colspan="1">Range</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1"/><td colspan="2" rowspan="1">24&#x02013;64</td></tr><tr><td rowspan="1" colspan="1">Participants with high CRP (years)<xref ref-type="table-fn" rid="tfn2_4">&#x02021;</xref></td><td rowspan="1" colspan="1">50&#x000b7;6</td><td rowspan="1" colspan="1">12&#x000b7;3</td><td rowspan="1" colspan="1"/><td colspan="2" rowspan="1">24&#x02013;64</td></tr><tr><td rowspan="1" colspan="1">Participants with low CRP (years)<xref ref-type="table-fn" rid="tfn2_4">&#x02021;</xref></td><td rowspan="1" colspan="1">47&#x000b7;9</td><td rowspan="1" colspan="1">9&#x000b7;4</td><td rowspan="1" colspan="1"/><td colspan="2" rowspan="1">25&#x02013;57</td></tr><tr><td rowspan="1" colspan="1">Weight (kg)</td><td rowspan="1" colspan="1">90&#x000b7;5</td><td rowspan="1" colspan="1">9&#x000b7;5</td><td rowspan="1" colspan="1"/><td colspan="2" rowspan="1">66&#x000b7;1&#x02013;109&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">Height (m)</td><td rowspan="1" colspan="1">1&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1"/><td colspan="2" rowspan="1">1&#x000b7;5&#x02013;1&#x000b7;8</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">31&#x000b7;7</td><td rowspan="1" colspan="1">2&#x000b7;9</td><td rowspan="1" colspan="1"/><td colspan="2" rowspan="1">24&#x000b7;4&#x02013;37&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1">WC (inches)</td><td rowspan="1" colspan="1">38&#x000b7;7</td><td rowspan="1" colspan="1">2&#x000b7;4</td><td rowspan="1" colspan="1"/><td colspan="2" rowspan="1">32&#x02013;42&#x000b7;4</td></tr><tr><td rowspan="1" colspan="1">WC, males (inches)<xref ref-type="table-fn" rid="tfn2_5">&#x000a7;</xref></td><td rowspan="1" colspan="1">39&#x000b7;4</td><td rowspan="1" colspan="1">1&#x000b7;3</td><td rowspan="1" colspan="1">&#x0003e;40</td><td colspan="2" rowspan="1">37&#x000b7;2&#x02013;41</td></tr><tr><td rowspan="1" colspan="1">WC, females (inches)<xref ref-type="table-fn" rid="tfn2_5">&#x000a7;</xref></td><td rowspan="1" colspan="1">38&#x000b7;3</td><td rowspan="1" colspan="1">2&#x000b7;8</td><td rowspan="1" colspan="1">&#x0003e;35</td><td colspan="2" rowspan="1">32&#x02013;42&#x000b7;4</td></tr><tr><td rowspan="1" colspan="1">WC (cm)</td><td rowspan="1" colspan="1">98&#x000b7;3</td><td rowspan="1" colspan="1">6&#x000b7;1</td><td rowspan="1" colspan="1"/><td colspan="2" rowspan="1">81&#x02013;107&#x000b7;7</td></tr><tr><td rowspan="1" colspan="1">WC, males (cm)<xref ref-type="table-fn" rid="tfn2_5">&#x000a7;</xref></td><td rowspan="1" colspan="1">100&#x000b7;1</td><td rowspan="1" colspan="1">3&#x000b7;3</td><td rowspan="1" colspan="1">&#x0003e;102</td><td colspan="2" rowspan="1">94&#x000b7;5&#x02013;104&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1">WC, females (cm)<xref ref-type="table-fn" rid="tfn2_5">&#x000a7;</xref></td><td rowspan="1" colspan="1">97&#x000b7;3</td><td rowspan="1" colspan="1">7&#x000b7;1</td><td rowspan="1" colspan="1">&#x0003e;89</td><td colspan="2" rowspan="1">81&#x000b7;3&#x02013;107&#x000b7;7</td></tr><tr><td rowspan="1" colspan="1">Systolic BP (mmHg)</td><td rowspan="1" colspan="1">127</td><td rowspan="1" colspan="1">14&#x000b7;1</td><td rowspan="1" colspan="1">&#x02265;130</td><td colspan="2" rowspan="1">98&#x02013;151&#x000b7;5</td></tr><tr><td rowspan="1" colspan="1">Diastolic BP (mmHg)</td><td rowspan="1" colspan="1">78&#x000b7;1</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">&#x02265;85</td><td rowspan="1" colspan="1">57&#x02013;98&#x000b7;5</td></tr><tr><td rowspan="1" colspan="1">HDL-cholesterol</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">mg/dl</td><td rowspan="1" colspan="1">45&#x000b7;9</td><td rowspan="1" colspan="1">9&#x000b7;7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">31&#x02013;60</td></tr><tr><td rowspan="1" colspan="1">mmol/l</td><td rowspan="1" colspan="1">1&#x000b7;19</td><td rowspan="1" colspan="1">0&#x000b7;25</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0&#x000b7;80&#x02013;1&#x000b7;55</td></tr><tr><td rowspan="1" colspan="1">HDL-cholesterol, male<xref ref-type="table-fn" rid="tfn2_5">&#x000a7;</xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;mg/dl</td><td rowspan="1" colspan="1">41&#x000b7;9</td><td rowspan="1" colspan="1">10&#x000b7;3</td><td rowspan="1" colspan="1">&#x0003c;40</td><td rowspan="1" colspan="1">31&#x02013;56</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;mmol/l</td><td rowspan="1" colspan="1">1&#x000b7;08</td><td rowspan="1" colspan="1">0&#x000b7;27</td><td rowspan="1" colspan="1">&#x0003c;1&#x000b7;03</td><td rowspan="1" colspan="1">0&#x000b7;80&#x02013;1&#x000b7;45</td></tr><tr><td rowspan="1" colspan="1">HDL-cholesterol, female<xref ref-type="table-fn" rid="tfn2_5">&#x000a7;</xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;mg/dl</td><td rowspan="1" colspan="1">48&#x000b7;1</td><td rowspan="1" colspan="1">9&#x000b7;0</td><td rowspan="1" colspan="1">&#x0003c;50</td><td rowspan="1" colspan="1">33&#x02013;60</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;mmol/l</td><td rowspan="1" colspan="1">1&#x000b7;24</td><td rowspan="1" colspan="1">0&#x000b7;23</td><td rowspan="1" colspan="1">&#x0003c;1&#x000b7;29</td><td rowspan="1" colspan="1">0&#x000b7;85&#x02013;1&#x000b7;55</td></tr><tr><td rowspan="1" colspan="1">Fasting glucose</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">mg/dl</td><td rowspan="1" colspan="1">91&#x000b7;8</td><td rowspan="1" colspan="1">7&#x000b7;4</td><td rowspan="1" colspan="1">&#x02265;100</td><td rowspan="1" colspan="1">78&#x02013;104</td></tr><tr><td rowspan="1" colspan="1">mmol/l</td><td rowspan="1" colspan="1">5&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;4</td><td rowspan="1" colspan="1">&#x02265;5&#x000b7;6</td><td rowspan="1" colspan="1">4&#x000b7;3&#x02013;5&#x000b7;8</td></tr><tr><td rowspan="1" colspan="1">Fasting TAG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">mg/dl</td><td rowspan="1" colspan="1">124&#x000b7;4</td><td rowspan="1" colspan="1">45&#x000b7;7</td><td rowspan="1" colspan="1">&#x02265;150</td><td rowspan="1" colspan="1">65&#x02013;224</td></tr><tr><td rowspan="1" colspan="1">mmol/l</td><td rowspan="1" colspan="1">1&#x000b7;40</td><td rowspan="1" colspan="1">0&#x000b7;52</td><td rowspan="1" colspan="1">&#x02265;1&#x000b7;69</td><td rowspan="1" colspan="1">0&#x000b7;73&#x02013;2&#x000b7;53</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>MetS, metabolic syndrome; CRP, C-reactive protein; WC, waist circumference; BP,
blood pressure.</p></fn><fn id="tfn2_2"><label>*</label><p>Measurements taken at screening visit (<italic>n</italic> 20).</p></fn><fn id="tfn2_3"><label>&#x02020;</label><p>MetS as defined by the American Heart Associations.</p></fn><fn id="tfn2_4"><label>&#x02021;</label><p>High baseline CRP <italic>n</italic> 10; low baseline CRP <italic>n</italic>
10.</p></fn><fn id="tfn2_5"><label>&#x000a7;</label><p>Male <italic>n</italic> 7; female <italic>n</italic> 13.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec2-2"><title>Dietary intake</title><p>Dietary analysis of the 1-d food record completed prior to each test day revealed no
significant differences in consumption of macro- and micronutrients (data not shown).</p></sec><sec id="sec2-3"><title>Metabolic parameters</title><p>Baseline and postprandial changes for metabolic markers (total cholesterol, HDL, LDL,
TAG) are shown in <xref ref-type="table" rid="tab03">Table 3</xref>. No time&#x000a0;&#x000d7;&#x000a0;treatment
interaction or main effect of treatment were observed for any of these markers; however,
there was a significant difference over time for all markers. <table-wrap id="tab03" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Concentrations of metabolic parameters before and after dietary challenge (Pooled
mean values and standard deviations)<xref ref-type="table-fn" rid="tfn3_1">*</xref></p></caption><alternatives><graphic xlink:href="S2048679015000403_tab3"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="11" rowspan="1">Time</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">0&#x000a0;h</th><th align="center" colspan="2" rowspan="1">1&#x000a0;h</th><th align="center" colspan="2" rowspan="1">3&#x000a0;h</th><th align="center" colspan="2" rowspan="1">6&#x000a0;h</th><th align="center" colspan="3" rowspan="1">
<italic>P</italic>
</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Treatment</th><th align="center" rowspan="1" colspan="1">Time</th><th align="center" rowspan="1" colspan="1">Interaction</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Total cholesterol</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0&#x000b7;87</td><td rowspan="1" colspan="1">0&#x000b7;001</td><td rowspan="1" colspan="1">0&#x000b7;96</td></tr><tr><td rowspan="1" colspan="1">mg/dl</td><td rowspan="1" colspan="1">209&#x000b7;0</td><td rowspan="1" colspan="1">44&#x000b7;3</td><td rowspan="1" colspan="1">215&#x000b7;1</td><td rowspan="1" colspan="1">45&#x000b7;2</td><td rowspan="1" colspan="1">209&#x000b7;9</td><td rowspan="1" colspan="1">42&#x000b7;4</td><td rowspan="1" colspan="1">212&#x000b7;2</td><td rowspan="1" colspan="1">45&#x000b7;6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">mmol/l</td><td rowspan="1" colspan="1">5&#x000b7;41</td><td rowspan="1" colspan="1">1&#x000b7;15</td><td rowspan="1" colspan="1">5&#x000b7;57</td><td rowspan="1" colspan="1">1&#x000b7;17</td><td rowspan="1" colspan="1">5&#x000b7;44</td><td rowspan="1" colspan="1">1&#x000b7;10</td><td rowspan="1" colspan="1">5&#x000b7;50</td><td rowspan="1" colspan="1">1&#x000b7;18</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">HDL-cholesterol</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0&#x000b7;95</td><td rowspan="1" colspan="1">0&#x000b7;002</td><td rowspan="1" colspan="1">0&#x000b7;51</td></tr><tr><td rowspan="1" colspan="1">mg/dl</td><td rowspan="1" colspan="1">47&#x000b7;3</td><td rowspan="1" colspan="1">10&#x000b7;9</td><td rowspan="1" colspan="1">48&#x000b7;3</td><td rowspan="1" colspan="1">11&#x000b7;4</td><td rowspan="1" colspan="1">45&#x000b7;8</td><td rowspan="1" colspan="1">10&#x000b7;0</td><td rowspan="1" colspan="1">45&#x000b7;7</td><td rowspan="1" colspan="1">10&#x000b7;5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">mmol/l</td><td rowspan="1" colspan="1">1&#x000b7;23</td><td rowspan="1" colspan="1">0&#x000b7;28</td><td rowspan="1" colspan="1">1&#x000b7;25</td><td rowspan="1" colspan="1">0&#x000b7;30</td><td rowspan="1" colspan="1">1&#x000b7;19</td><td rowspan="1" colspan="1">0&#x000b7;26</td><td rowspan="1" colspan="1">1&#x000b7;18</td><td rowspan="1" colspan="1">0&#x000b7;27</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">LDL-cholesterol</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0&#x000b7;98</td><td rowspan="1" colspan="1">&#x0003c;0&#x000b7;0005</td><td rowspan="1" colspan="1">0&#x000b7;24</td></tr><tr><td rowspan="1" colspan="1">mg/dl</td><td rowspan="1" colspan="1">135&#x000b7;8</td><td rowspan="1" colspan="1">38&#x000b7;5</td><td rowspan="1" colspan="1">132&#x000b7;4</td><td rowspan="1" colspan="1">38&#x000b7;8</td><td rowspan="1" colspan="1">126&#x000b7;2</td><td rowspan="1" colspan="1">36&#x000b7;4</td><td rowspan="1" colspan="1">124&#x000b7;6</td><td rowspan="1" colspan="1">41&#x000b7;1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">mmol/l</td><td rowspan="1" colspan="1">3&#x000b7;52</td><td rowspan="1" colspan="1">1&#x000b7;00</td><td rowspan="1" colspan="1">3&#x000b7;43</td><td rowspan="1" colspan="1">1&#x000b7;00</td><td rowspan="1" colspan="1">3&#x000b7;27</td><td rowspan="1" colspan="1">0&#x000b7;94</td><td rowspan="1" colspan="1">3&#x000b7;23</td><td rowspan="1" colspan="1">1&#x000b7;06</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">HDL:LDL</td><td rowspan="1" colspan="1">4&#x000b7;6</td><td rowspan="1" colspan="1">1&#x000b7;1</td><td rowspan="1" colspan="1">4&#x000b7;6</td><td rowspan="1" colspan="1">1&#x000b7;0</td><td rowspan="1" colspan="1">4&#x000b7;7</td><td rowspan="1" colspan="1">1&#x000b7;1</td><td rowspan="1" colspan="1">4&#x000b7;7</td><td rowspan="1" colspan="1">1&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;93</td><td rowspan="1" colspan="1">&#x0003c;0&#x000b7;0005</td><td rowspan="1" colspan="1">0&#x000b7;38</td></tr><tr><td rowspan="1" colspan="1">TAG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0&#x000b7;60</td><td rowspan="1" colspan="1">&#x0003c;0&#x000b7;0005</td><td rowspan="1" colspan="1">0&#x000b7;67</td></tr><tr><td rowspan="1" colspan="1">mg/dl</td><td rowspan="1" colspan="1">129&#x000b7;0</td><td rowspan="1" colspan="1">44&#x000b7;4</td><td rowspan="1" colspan="1">171&#x000b7;2</td><td rowspan="1" colspan="1">54&#x000b7;7</td><td rowspan="1" colspan="1">199&#x000b7;9</td><td rowspan="1" colspan="1">75&#x000b7;2</td><td rowspan="1" colspan="1">218&#x000b7;6</td><td rowspan="1" colspan="1">77&#x000b7;4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">mmol/l</td><td rowspan="1" colspan="1">1&#x000b7;46</td><td rowspan="1" colspan="1">0&#x000b7;50</td><td rowspan="1" colspan="1">1&#x000b7;93</td><td rowspan="1" colspan="1">0&#x000b7;62</td><td rowspan="1" colspan="1">2&#x000b7;26</td><td rowspan="1" colspan="1">0&#x000b7;85</td><td rowspan="1" colspan="1">2&#x000b7;47</td><td rowspan="1" colspan="1">0&#x000b7;87</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Non-HDL-cholesterol</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0&#x000b7;88</td><td rowspan="1" colspan="1">&#x0003c;0&#x000b7;0005</td><td rowspan="1" colspan="1">0&#x000b7;59</td></tr><tr><td rowspan="1" colspan="1">mg/dl</td><td rowspan="1" colspan="1">161&#x000b7;6</td><td rowspan="1" colspan="1">41&#x000b7;7</td><td rowspan="1" colspan="1">166&#x000b7;7</td><td rowspan="1" colspan="1">42&#x000b7;4</td><td rowspan="1" colspan="1">164&#x000b7;1</td><td rowspan="1" colspan="1">40&#x000b7;3</td><td rowspan="1" colspan="1">166&#x000b7;4</td><td rowspan="1" colspan="1">43&#x000b7;6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">mmol/l</td><td rowspan="1" colspan="1">4&#x000b7;19</td><td rowspan="1" colspan="1">1&#x000b7;08</td><td rowspan="1" colspan="1">4&#x000b7;32</td><td rowspan="1" colspan="1">1&#x000b7;10</td><td rowspan="1" colspan="1">4&#x000b7;25</td><td rowspan="1" colspan="1">1&#x000b7;04</td><td rowspan="1" colspan="1">4&#x000b7;31</td><td rowspan="1" colspan="1">1&#x000b7;13</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="tfn3_1"><label>*</label><p>Values are pooled means of both treatments since there was no treatment
effect.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec2-4"><title>Postprandial glycaemia</title><p>At baseline, insulin concentrations did not differ between test days
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;8) while glucose concentrations did (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;004);
however, since there was no treatment effect this statistical difference was considered a
random occurrence. Following each meal, there was a rapid increase in both glucose and
insulin from 0 to 1&#x000a0;h (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;029 and <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;0005,
respectively) followed by a decrease from 1 to 3&#x000a0;h (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;0005 for
both) and an increase in glucose from 3 to 6&#x000a0;h (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;01). The glucose
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;602) and insulin (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;908) responses did not
differ between the treatments (<xref ref-type="fig" rid="fig02">Fig. 2</xref>). <fig id="fig02" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p>Postprandial response of glucose (a) and insulin (b) before and after high-fat
mixed meal rich in SFA from either vegan alternative cheese (---) or Cheddar cheese
(&#x02013;&#x02013;). Values are means, with standard deviations represented by vertical bars
(<italic>n</italic> 20). * Significant difference between 0 and 1&#x000a0;h
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;0005). &#x02020; Significant difference between 1 and 3&#x000a0;h
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;0005). &#x02021; Significant difference between 3 and 6&#x000a0;h
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;01).</p></caption><graphic xlink:href="S2048679015000403_fig2"/></fig></p></sec><sec id="sec2-5"><title>Postprandial lipaemia</title><p>Fasting/baseline TAG concentrations were comparable between the two treatments
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;245). After meal consumption, postprandial TAG concentration rose
steadily (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05 for all time points: 0&#x02013;1, 0&#x02013;3, 0&#x02013;6, 1&#x02013;3, 1&#x02013;6,
and 3&#x02013;6&#x000a0;h) with no sign of a decrease at the 6&#x000a0;h time point (<xref ref-type="fig" rid="fig03">Fig. 3</xref>). <fig id="fig03" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p>Postprandial response of serum TAG after both vegan alternative (---) and Cheddar
cheese (&#x02013;&#x02013;) meals. Values are means, with standard deviations represented by
vertical bars (<italic>n</italic> 20). There was no difference between the
treatments but there was a significant increase over time
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05) for all time points: 0&#x02013;1, 0&#x02013;3, 0&#x02013;6, 1&#x02013;3, 1&#x02013;6, and
3&#x02013;6&#x000a0;h.</p></caption><graphic xlink:href="S2048679015000403_fig3"/></fig></p></sec><sec id="sec2-6"><title>Inflammatory markers</title><p>IL-1&#x003b2; and IL-2 were below the detection limit (for about 70 and 35&#x000a0;% of samples,
respectively) and therefore, excluded from the statistical analysis. Similar results for
these two particular cytokines have been observed<sup>(</sup><xref rid="ref33" ref-type="bibr">
<sup>33</sup>
</xref><sup>)</sup>. Baseline concentrations of all markers related to inflammation were
comparable between the two interventions. CRP as the iAUC was the only marker with a
significant difference between treatments, with the VA meal resulting in a significantly
greater overall CRP concentration (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;033) when compared with the CH
meal (<xref ref-type="fig" rid="fig04">Fig. 4</xref>). There was no treatment effect
observed for any of the other inflammatory markers. However, multiple markers did
demonstrate an effect over time; SAA peaked at 1&#x000a0;h postprandially, IL-8 peaked at 3&#x000a0;h,
while IL-6, IL-18, MCP-1 and TNF&#x003b1; peaked at 6&#x000a0;h postprandially (<xref ref-type="table" rid="tab04">Table 4</xref>). Secondary analyses based on baseline CRP values indicated
that those with pre-existing fasting CRP concentrations &#x02265;3&#x000a0;mg/l did not have a different
response to treatment compared with participants with baseline CRP concentrations
&#x0003c;3&#x000a0;mg/l. We conducted a secondary analysis using baseline CRP concentrations as a
stratification and found that volunteers who had a baseline CRP value &#x0003e;3&#x000a0;mg/l had
significantly higher concentrations of IL-6, SAA and sICAM at each time point compared
with the subjects who had baseline CRP values &#x0003c;3&#x000a0;mg/l. <fig id="fig04" orientation="portrait" position="float"><label>Fig. 4.</label><caption><p>Postprandial serum C-reactive protein (CRP) concentrations over the 6&#x000a0;h
postprandial period after the Cheddar cheese (CH) and vegan alternative (VA) meals.
Values are means, with standard deviations represented by vertical bars. * The VA
meal resulted in a significantly greater overall CRP concentration
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;033) when compared with the CH meal. iAUC, incremental
AUC.</p></caption><graphic xlink:href="S2048679015000403_fig4"/></fig>
<table-wrap id="tab04" orientation="portrait" position="float"><label>Table 4.</label><caption><p>Concentrations of inflammatory markers before and after the dietary challenge
(Pooled mean values and standard deviations)<xref ref-type="table-fn" rid="tfn4_2">*</xref></p></caption><alternatives><graphic xlink:href="S2048679015000403_tab4"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="8" rowspan="1">Time</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">0&#x000a0;h</th><th align="center" colspan="2" rowspan="1">1&#x000a0;h</th><th align="center" colspan="2" rowspan="1">3&#x000a0;h</th><th align="center" colspan="2" rowspan="1">6&#x000a0;h</th><th align="center" colspan="5" rowspan="1">
<italic>P</italic>
</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Treatment</th><th align="center" rowspan="1" colspan="1">Time</th><th align="center" rowspan="1" colspan="1">Interaction</th><th align="center" rowspan="1" colspan="1">LLOD<xref ref-type="table-fn" rid="tfn4_3">&#x02020;</xref></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">IL-6 (pg/ml)</td><td rowspan="1" colspan="1">0&#x000b7;94</td><td rowspan="1" colspan="1">0&#x000b7;64</td><td rowspan="1" colspan="1">0&#x000b7;79</td><td rowspan="1" colspan="1">0&#x000b7;63</td><td rowspan="1" colspan="1">0&#x000b7;94</td><td rowspan="1" colspan="1">0&#x000b7;77</td><td rowspan="1" colspan="1">1&#x000b7;16</td><td rowspan="1" colspan="1">1&#x000b7;15</td><td rowspan="1" colspan="1">0&#x000b7;818</td><td rowspan="1" colspan="1">0&#x000b7;001</td><td rowspan="1" colspan="1">0&#x000b7;146</td><td rowspan="1" colspan="1">0&#x000b7;06</td></tr><tr><td rowspan="1" colspan="1">IL-8 (pg/ml)</td><td rowspan="1" colspan="1">8&#x000b7;46</td><td rowspan="1" colspan="1">2&#x000b7;60</td><td rowspan="1" colspan="1">9&#x000b7;06</td><td rowspan="1" colspan="1">2&#x000b7;51</td><td rowspan="1" colspan="1">9&#x000b7;47</td><td rowspan="1" colspan="1">2&#x000b7;46</td><td rowspan="1" colspan="1">8&#x000b7;48</td><td rowspan="1" colspan="1">2&#x000b7;63</td><td rowspan="1" colspan="1">0&#x000b7;97</td><td rowspan="1" colspan="1">0&#x000b7;004</td><td rowspan="1" colspan="1">0&#x000b7;866</td><td rowspan="1" colspan="1">0&#x000b7;04</td></tr><tr><td rowspan="1" colspan="1">IL-10 (pg/ml)</td><td rowspan="1" colspan="1">6&#x000b7;94</td><td rowspan="1" colspan="1">17&#x000b7;99</td><td rowspan="1" colspan="1">6&#x000b7;69</td><td rowspan="1" colspan="1">16&#x000b7;44</td><td rowspan="1" colspan="1">7&#x000b7;14</td><td rowspan="1" colspan="1">18&#x000b7;73</td><td rowspan="1" colspan="1">7&#x000b7;30</td><td rowspan="1" colspan="1">18&#x000b7;13</td><td rowspan="1" colspan="1">0&#x000b7;989</td><td rowspan="1" colspan="1">0&#x000b7;305</td><td rowspan="1" colspan="1">0&#x000b7;459</td><td rowspan="1" colspan="1">0&#x000b7;03</td></tr><tr><td rowspan="1" colspan="1">IL-17 (pg/ml)</td><td rowspan="1" colspan="1">3&#x000b7;08</td><td rowspan="1" colspan="1">4&#x000b7;35</td><td rowspan="1" colspan="1">3&#x000b7;11</td><td rowspan="1" colspan="1">4&#x000b7;89</td><td rowspan="1" colspan="1">3&#x000b7;40</td><td rowspan="1" colspan="1">4&#x000b7;71</td><td rowspan="1" colspan="1">4&#x000b7;10</td><td rowspan="1" colspan="1">7&#x000b7;62</td><td rowspan="1" colspan="1">0&#x000b7;889</td><td rowspan="1" colspan="1">0&#x000b7;681</td><td rowspan="1" colspan="1">0&#x000b7;155</td><td rowspan="1" colspan="1">0&#x000b7;74</td></tr><tr><td rowspan="1" colspan="1">IL-18 (pg/ml)</td><td rowspan="1" colspan="1">35&#x000b7;85</td><td rowspan="1" colspan="1">23&#x000b7;24</td><td rowspan="1" colspan="1">38&#x000b7;63</td><td rowspan="1" colspan="1">25&#x000b7;24</td><td rowspan="1" colspan="1">37&#x000b7;05</td><td rowspan="1" colspan="1">24&#x000b7;17</td><td rowspan="1" colspan="1">39&#x000b7;35</td><td rowspan="1" colspan="1">23&#x000b7;43</td><td rowspan="1" colspan="1">0&#x000b7;958</td><td rowspan="1" colspan="1">0&#x000b7;001</td><td rowspan="1" colspan="1">0&#x000b7;217</td><td rowspan="1" colspan="1">0&#x000b7;71</td></tr><tr><td rowspan="1" colspan="1">TNF&#x003b1; (pg/ml)</td><td rowspan="1" colspan="1">1&#x000b7;95</td><td rowspan="1" colspan="1">0&#x000b7;82</td><td rowspan="1" colspan="1">1&#x000b7;99</td><td rowspan="1" colspan="1">0&#x000b7;79</td><td rowspan="1" colspan="1">2&#x000b7;03</td><td rowspan="1" colspan="1">0&#x000b7;79</td><td rowspan="1" colspan="1">2&#x000b7;07</td><td rowspan="1" colspan="1">0&#x000b7;89</td><td rowspan="1" colspan="1">0&#x000b7;836</td><td rowspan="1" colspan="1">0&#x000b7;001</td><td rowspan="1" colspan="1">0&#x000b7;267</td><td rowspan="1" colspan="1">0&#x000b7;04</td></tr><tr><td rowspan="1" colspan="1">MCP-1 (pg/ml)</td><td rowspan="1" colspan="1">456&#x000b7;7</td><td rowspan="1" colspan="1">238&#x000b7;5</td><td rowspan="1" colspan="1">496&#x000b7;8</td><td rowspan="1" colspan="1">228&#x000b7;2</td><td rowspan="1" colspan="1">498&#x000b7;4</td><td rowspan="1" colspan="1">246&#x000b7;5</td><td rowspan="1" colspan="1">521&#x000b7;8</td><td rowspan="1" colspan="1">238&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;645</td><td rowspan="1" colspan="1">0&#x000b7;001</td><td rowspan="1" colspan="1">0&#x000b7;599</td><td rowspan="1" colspan="1">0&#x000b7;09</td></tr><tr><td rowspan="1" colspan="1">CRP (mg/l)</td><td rowspan="1" colspan="1">4&#x000b7;57</td><td rowspan="1" colspan="1">5&#x000b7;00</td><td rowspan="1" colspan="1">4&#x000b7;72</td><td rowspan="1" colspan="1">5&#x000b7;32</td><td rowspan="1" colspan="1">4&#x000b7;46</td><td rowspan="1" colspan="1">5&#x000b7;42</td><td rowspan="1" colspan="1">4&#x000b7;52</td><td rowspan="1" colspan="1">5&#x000b7;21</td><td rowspan="1" colspan="1">0&#x000b7;588</td><td rowspan="1" colspan="1">0&#x000b7;256</td><td rowspan="1" colspan="1">0&#x000b7;414</td><td rowspan="1" colspan="1">1&#x000b7;33&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;6</sup></td></tr><tr><td rowspan="1" colspan="1">SAA (mg/l)</td><td rowspan="1" colspan="1">9&#x000b7;21</td><td rowspan="1" colspan="1">8&#x000b7;92</td><td rowspan="1" colspan="1">9&#x000b7;51</td><td rowspan="1" colspan="1">9&#x000b7;48</td><td rowspan="1" colspan="1">9&#x000b7;13</td><td rowspan="1" colspan="1">10&#x000b7;12</td><td rowspan="1" colspan="1">8&#x000b7;52</td><td rowspan="1" colspan="1">9&#x000b7;44</td><td rowspan="1" colspan="1">0&#x000b7;473</td><td rowspan="1" colspan="1">0&#x000b7;023</td><td rowspan="1" colspan="1">0&#x000b7;361</td><td rowspan="1" colspan="1">1&#x000b7;09&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;5</sup></td></tr><tr><td rowspan="1" colspan="1">sICAM (mg/l)</td><td rowspan="1" colspan="1">0&#x000b7;28</td><td rowspan="1" colspan="1">0&#x000b7;09</td><td rowspan="1" colspan="1">0&#x000b7;30</td><td rowspan="1" colspan="1">0&#x000b7;16</td><td rowspan="1" colspan="1">0&#x000b7;29</td><td rowspan="1" colspan="1">0&#x000b7;14</td><td rowspan="1" colspan="1">0&#x000b7;27</td><td rowspan="1" colspan="1">0&#x000b7;09</td><td rowspan="1" colspan="1">0&#x000b7;629</td><td rowspan="1" colspan="1">0&#x000b7;427</td><td rowspan="1" colspan="1">0&#x000b7;834</td><td rowspan="1" colspan="1">1&#x000b7;03&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;6</sup></td></tr><tr><td rowspan="1" colspan="1">sVCAM (mg/l)</td><td rowspan="1" colspan="1">0&#x000b7;42</td><td rowspan="1" colspan="1">0&#x000b7;10</td><td rowspan="1" colspan="1">0&#x000b7;45</td><td rowspan="1" colspan="1">0&#x000b7;22</td><td rowspan="1" colspan="1">0&#x000b7;46</td><td rowspan="1" colspan="1">0&#x000b7;20</td><td rowspan="1" colspan="1">0&#x000b7;42</td><td rowspan="1" colspan="1">0&#x000b7;13</td><td rowspan="1" colspan="1">0&#x000b7;637</td><td rowspan="1" colspan="1">0&#x000b7;317</td><td rowspan="1" colspan="1">0&#x000b7;467</td><td align="left" rowspan="1" colspan="1">6&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;6</sup></td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>LLOD, lower limit of detection; MCP-1, monocyte chemotactic protein-1; CRP,
C-reactive protein; SAA, serum amyloid-A; sICAM, soluble intracellular adhesion
molecule; sVCAM, soluble vascular adhesion molecule.</p></fn><fn id="tfn4_2"><label>*</label><p>Values are pooled means of both treatments since there was no treatment
effect.</p></fn><fn id="tfn4_3"><label>&#x02020;</label><p>Values from Meso Scale Discovery.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec sec-type="discussion" id="sec3"><title>Discussion</title><p>In this study, more than half (55&#x000a0;%) of the measured serum inflammatory markers (IL-6,
IL-8, IL-18, TNF&#x003b1;, MCP-1 and SAA) significantly changed over the 6&#x000a0;h postprandial period
from baseline. Some of these findings are consistent and some are not consistent with
previous findings. Based on the literature we had expected IL-6 to increase after the
high-fat challenges and peak around the 3&#x000a0;h time point, which has previously been observed
in men with the metabolic syndrome<sup>(</sup><xref rid="ref34" ref-type="bibr">
<sup>34</sup>
</xref><sup>)</sup>, overweight, obese men and women<sup>(</sup><xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref><sup>,</sup><xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref><sup>,</sup><xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref><sup>)</sup>, and healthy participants<sup>(</sup><xref rid="ref37" ref-type="bibr">
<sup>37</sup>
</xref><sup>,</sup><xref rid="ref38" ref-type="bibr">
<sup>38</sup>
</xref><sup>)</sup>. However, to our surprise, the results presented here showed an initial
decrease in serum IL-6 concentration from baseline to the 1&#x000a0;h time point after consuming
both high-fat meals, followed by a significant rise at 3&#x000a0;h. Manning <italic>et
al</italic>.<sup>(</sup><xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref><sup>)</sup> reported similar findings of a temporary decrease in IL-6 at 1&#x000a0;h after
five test meals rich in cream, olive oil, rapeseed oil, potato or All-Bran in obese and
healthy women, suggesting this might be due to the anti-inflammatory effects of
insulin<sup>(</sup><xref rid="ref39" ref-type="bibr">
<sup>39</sup>
</xref><sup>)</sup>. Our results support this, as insulin peaked at 1&#x000a0;h, the time at which
IL-6 concentrations were lowest.</p><p>IL-8 has not been commonly included in high-fat postprandial inflammation
studies<sup>(</sup><xref rid="ref30" ref-type="bibr">
<sup>30</sup>
</xref><sup>)</sup>; however, one postprandial study found no change over time in overweight
men<sup>(</sup><xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref><sup>)</sup> or in healthy or obese women<sup>(</sup><xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref><sup>)</sup>. IL-8 plays an important role in atherosclerosis in part by stimulating
the production of other pro-inflammatory cytokines such as TNF&#x003b1; and IL-1&#x003b2;<sup>(</sup><xref rid="ref40" ref-type="bibr">
<sup>40</sup>
</xref><sup>)</sup>. Our results showed an initial rise in IL-8 concentrations after both
treatments with a peak at the 3&#x000a0;h time point. An increase in IL-18 has been linked to CVD as
it is a powerful cytokine whose functions include the production of pro-inflammatory
cytokines such as TNF&#x003b1;, IL-1&#x003b2;, sICAM and soluble vascular adhesion molecule<sup>(</sup><xref rid="ref41" ref-type="bibr">
<sup>41</sup>
</xref><sup>)</sup>. We are one of the first groups to analyse the postprandial response of
IL-18 after a high-fat challenge. Our results showed a significant increase in IL-18 after
both high-fat treatments, complemented by a similar increase in TNF&#x003b1;.</p><p>TNF&#x003b1;, a cytokine commonly measured in the postprandial state, significantly increased after
consumption of a large lipid load and peaked at 6&#x000a0;h. These data are consistent with several
reports in healthy, type 2 diabetic, overweight, and obese men and women after high-fat test
meals<sup>(</sup><xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref><sup>,</sup><xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref><sup>,</sup><xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref><sup>,</sup><xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref><sup>,</sup><xref rid="ref38" ref-type="bibr">
<sup>38</sup>
</xref><sup>)</sup>. These data may be explained by a greater number of monocytes in
circulation after a high-fat meal<sup>(</sup><xref rid="ref42" ref-type="bibr">
<sup>42</sup>
</xref><sup>)</sup> and the rise in IL-8 and IL-18 at 3&#x000a0;h. While we do not have data on
lymphocyte count for this study, it would be of interest for future studies to incorporate
this analysis. Our results showed a significant increase in MCP-1 from baseline at 1, 3 and
6&#x000a0;h after both meals. Similar results have been reported previously in patients with the
metabolic syndrome who consumed a high-saturated fat meal<sup>(</sup><xref rid="ref43" ref-type="bibr">
<sup>43</sup>
</xref><sup>)</sup>. However, not all studies have observed this postprandial increase.
Masson &#x00026; Mensink<sup>(</sup><xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref><sup>)</sup> found a significant decrease in serum MCP-1 in overweight men after both
high-fat meals that provided a total of 50&#x000a0;g of fat (butter <italic>v</italic>. linoleic
acid). In our study, the majority of the participants were women and fat in the test meals
was provided as 50&#x000a0;% of each individual's total energy expenditure and ranged from 45 to
75&#x000a0;g. It is not known if the total amount of fat consumed or sex influence MCP-1 responses
in the postprandial period.</p><p>SAA, an acute-phase protein that is primarily synthesised by the liver, increases
several-fold during the inflammatory response to tissue injury<sup>(</sup><xref rid="ref44" ref-type="bibr">
<sup>44</sup>
</xref><sup>)</sup>. Its expression is stimulated by cytokines (IL-6, IL-1&#x003b2;,
TNF&#x003b1;)<sup>(</sup><xref rid="ref45" ref-type="bibr">
<sup>45</sup>
</xref><sup>)</sup>; however, SAA also stimulates the secretion of IL-6 in connective
tissue<sup>(</sup><xref rid="ref46" ref-type="bibr">
<sup>46</sup>
</xref><sup>)</sup>. SAA circulates in the blood as part of HDL particles. In this complex,
SAA mediates the binding of HDL to proteoglycans, promoting oxidation of the lipoprotein
which impairs its ability to remove cellular cholesterol, leading to cholesterol
accumulation in macrophages and foam cell formation<sup>(</sup><xref rid="ref47" ref-type="bibr">
<sup>47</sup>
</xref><sup>)</sup>. Based on SAA's ability to stimulate release of IL-6 by some tissues, we
expected to see a postprandial increase after the high-fat meals. Instead, our results
indicate a significant decrease from baseline at the 6&#x000a0;h time point similar to the decline
in HDL-cholesterol over the postprandial period. A similar decline in SAA concentration was
observed by Esser <italic>et al</italic>.<sup>(</sup><xref rid="ref48" ref-type="bibr">
<sup>48</sup>
</xref><sup>)</sup> after providing healthy men a high-fat meal, while an increase was seen
after the same volunteers consumed a lower-fat standard breakfast.</p><p>When the total concentration of each analyte over the 6&#x000a0;h postprandial time was calculated
as the iAUC, only CRP was different between the two test meals, with the VA meal resulting
in a significantly greater overall CRP concentration (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;033) when
compared with the CH meal. It is unknown what components in cheese could reduce CRP
concentration or what components in the vegan test meal could stimulate the increase in CRP
concentration over the 6&#x000a0;h postprandial time period. Schmid <italic>et
al</italic>.<sup>(</sup><xref rid="ref49" ref-type="bibr">
<sup>49</sup>
</xref><sup>)</sup> recently reported no difference in postprandial CRP after consumption of
a high-fat control or high-fat control with milk in normal-weight, overweight and obese men.
CRP is an acute-phase protein that is synthesised by the liver and increases several-fold
during the inflammatory response to tissue injury<sup>(</sup><xref rid="ref44" ref-type="bibr">
<sup>44</sup>
</xref><sup>)</sup> and responds to diet and exercise<sup>(</sup><xref rid="ref50" ref-type="bibr">
<sup>50</sup>
</xref><sup>,</sup><xref rid="ref51" ref-type="bibr">
<sup>51</sup>
</xref><sup>)</sup>. Its release by the liver is stimulated by IL-6 and alternatively, CRP
also induces secretion of IL-6 by endothelial cells<sup>(</sup><xref rid="ref52" ref-type="bibr">
<sup>52</sup>
</xref><sup>)</sup>. There are inconsistent findings on the effects of a high-fat test meal
on circulating CRP concentrations as a result of the composition of the test meals used,
target populations and timings of blood draws. For example, in lean individuals, plasma CRP
measured 24 h after consumption of a high-fat breakfast was significantly lower from
baseline when the breakfast contained a high <italic>v</italic>. low saturated:unsaturated
fat ratio<sup>(</sup><xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref><sup>)</sup>. Other reports have shown that CRP does not change within 6&#x000a0;h after
consumption of high-fat mixed meals in lean, overweight and abdominally obese
participants<sup>(</sup><xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref><sup>,</sup><xref rid="ref31" ref-type="bibr">
<sup>31</sup>
</xref><sup>,</sup><xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref><sup>,</sup><xref rid="ref49" ref-type="bibr">
<sup>49</sup>
</xref><sup>)</sup>. However, in type 2 diabetic participants, CRP significantly increased
from baseline within 4&#x000a0;h in response to a high-fat test meal<sup>(</sup><xref rid="ref53" ref-type="bibr">
<sup>53</sup>
</xref><sup>,</sup><xref rid="ref54" ref-type="bibr">
<sup>54</sup>
</xref><sup>)</sup>. In our study, the postprandial CRP response to the test meal could be
explained by the interaction between metabolic phenotype and the test meal<sup>(</sup><xref rid="ref31" ref-type="bibr">
<sup>31</sup>
</xref><sup>)</sup>. Perez-Martinez <italic>et al</italic>.<sup>(</sup><xref rid="ref31" ref-type="bibr">
<sup>31</sup>
</xref><sup>)</sup> recently reported higher postprandial plasma CRP to a high-fat meal in
metabolically abnormal subjects compared with normal, overweight and obese, metabolically
healthy patients. In our study, the majority of our participants were metabolically abnormal
according to elevated circulating CRP (&#x0003e;3&#x000a0;mg/l), insulin resistance
(HOMA-IR&#x000a0;&#x0003e;&#x000a0;2&#x000b7;6) and abdominal adiposity, yet we did not have enough statistical power
to determine the relationship between the test meal and metabolic phenotype.</p><p>In our study, participants had slightly elevated insulin concentrations at baseline as well
as high total and LDL-cholesterol levels, which were expected based on the inclusion
criteria. As expected, both high-fat challenges significantly increased plasma TAG
concentrations postprandially; however, the concentrations surprisingly peaked at 6&#x000a0;h. In
metabolically healthy individuals, the peak in plasma TAG after a high-fat mixed meal occurs
at about 4&#x000a0;h and declines by 6&#x000a0;h<sup>(</sup><xref rid="ref49" ref-type="bibr">
<sup>49</sup>
</xref><sup>,</sup><xref rid="ref55" ref-type="bibr">
<sup>55</sup>
</xref><sup>)</sup>. Because 70&#x000a0;% of our study participants were insulin resistant, it is
possible that the plateau in plasma TAG at 6&#x000a0;h is a result of their insulin resistance.
These data are supported by the report that the postprandial plasma TAG concentration was
found to plateau or peak at 6&#x000a0;h in individuals with pre-diabetes and type 2 diabetes, after
consumption of a mixed meal containing 62&#x000a0;g fat<sup>(</sup><xref rid="ref55" ref-type="bibr">
<sup>55</sup>
</xref><sup>)</sup>.</p><p>Postprandial lipaemia has been shown to be strongly associated with increased risk for
coronary artery disease<sup>(</sup><xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref><sup>)</sup>; however, while results from our study suggest that the consumption of a
meal enriched in SFA whether from Cheddar cheese or plant fat was sufficient to cause
postprandial lipaemia, the postprandial cytokine response in this subject pool was within
the normal range. Other studies have found that similar amounts of fat fed in mixed meals
did induce a lipaemic response and elicited postprandial inflammation<sup>(</sup><xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref><sup>,</sup><xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref><sup>)</sup>. In our study, the amount of fat used was high, with a mean of 59&#x000a0;g and
ranged 45&#x02013;75&#x000a0;g scaled to each individual's energy intake. Thus, we expected that
inflammatory responses would increase from baseline. It is possible that participants in
this study had delayed changes in postprandial inflammatory markers given that their TAG
levels were still increasing and possibly had not peaked yet by 6&#x000a0;h.</p><p>Cross-sectionally, dairy product consumption has been shown to be inversely correlated with
inflammatory markers among healthy adults<sup>(</sup><xref rid="ref56" ref-type="bibr">
<sup>56</sup>
</xref><sup>)</sup>. There are many possibilities to explain how the myriad components in
dairy products, their interactions and synergy upon digestion and metabolism could influence
postprandial inflammation. Dairy components that are reported to confer anti-inflammatory
effects include dairy proteins and peptides<sup>(</sup><xref rid="ref57" ref-type="bibr">
<sup>57</sup>
</xref><sup>)</sup>; SCFA<sup>(</sup><xref rid="ref11" ref-type="bibr">
<sup>11</sup>
</xref><sup>)</sup> as trophic factors for intestinal cells<sup>(</sup><xref rid="ref58" ref-type="bibr">
<sup>58</sup>
</xref><sup>)</sup>; starter and non-starter bacteria in fermented dairy
products<sup>(</sup><xref rid="ref12" ref-type="bibr">
<sup>12</sup>
</xref><sup>)</sup>; oligosaccharides as prebiotics<sup>(</sup><xref rid="ref59" ref-type="bibr">
<sup>59</sup>
</xref><sup>)</sup>; and milk fat globule membrane and its proteins and polar
lipids<sup>(</sup><xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref><sup>)</sup>. The effect of a meal composed of the dairy matrix as Cheddar cheese on
postprandial inflammation compared with a non-dairy cheese substitute enriched with SFA in
the form of palm oil has not been investigated. Palm oil was chosen as the source of SFA for
the non-dairy cheese alternative arm because it is commercially available, widely consumed
around the world and provides a similar SFA composition to dairy fat compared with other
plant-based fats.</p><p>The lack in finding a &#x02018;treatment&#x02019; effect to the high-fat test meals for several of the
inflammatory markers could be explained by several limitations. First, this study was
powered for postprandial changes in serum IL-6. Our sample size was not large enough to
permit statistical comparisons among different metabolic phenotypic groups (i.e. high
<italic>v</italic>. low CRP; insulin resistant <italic>v</italic>. sensitive, with or
without the metabolic syndrome). In our study, seven participants were diagnosed with the
metabolic syndrome and of the thirteen individuals without classical metabolic syndrome,
most had some metabolic abnormalities: five had elevated plasma CRP, nine were insulin
resistant, and ten had abdominal adiposity. Abdominal obesity is associated with a
pro-inflammatory state and shares features with the metabolic syndrome (for a review, see
Despr&#x000e9;s &#x00026; Lemieux<sup>(</sup><xref rid="ref60" ref-type="bibr">
<sup>60</sup>
</xref><sup>)</sup>), and 70&#x000a0;% of the participants had abdominal adiposity, yet, we did not
quantitatively differentiate between visceral <italic>v</italic>. subcutaneous obesity.
Additionally, the lack of significance may also result from the timing of blood collections
against the normal diurnal rhythm of inflammatory markers throughout the
day<sup>(</sup><xref rid="ref61" ref-type="bibr">
<sup>61</sup>
</xref><sup>)</sup>. We did not design the collection of time points to match the diurnal
patterns of serum inflammatory markers since these patterns vary for each inflammatory
marker. Yet, we did ensure that each time point was matched between the two test meals to
control for the time of day. While we observed a time effect for some of the inflammatory
markers it is important to note that all of these changes fell within the normal range for
each marker; thus the observed changes are probably fluctuations around
baseline<sup>(</sup><xref rid="ref34" ref-type="bibr">
<sup>34</sup>
</xref><sup>)</sup>. Furthermore, one possible explanation for the lack of a treatment
effect in all inflammatory markers measured is that the serum TAG had not yet peaked.
Another limitation of the study is that the test meals were not balanced for dietary Ca in
each treatment. The increased dietary Ca found in the CH meal could have formed Ca soaps and
thus lowered the amount of fatty acids that were absorbed. However, while some studies found
an effect of Ca from cheese on faecal fat excretion<sup>(</sup><xref rid="ref62" ref-type="bibr">
<sup>62</sup>
</xref><sup>)</sup>, others did not<sup>(</sup><xref rid="ref63" ref-type="bibr">
<sup>63</sup>
</xref><sup>)</sup>. Moreover, it would have been of interest to increase the sample size to
allow equal numbers of men and women in the study population as little is known about the
sex difference in inflammation. One study testing the inflammatory effect of a high-fat meal
in overweight men and women found IL-6 to be significantly more elevated in women than
men<sup>(</sup><xref rid="ref64" ref-type="bibr">
<sup>64</sup>
</xref><sup>)</sup>. Finally, it is not well known if postprandial inflammation is
influenced by the hormonal changes associated with the menstrual cycle as has been shown
with fasting circulating lipids<sup>(</sup><xref rid="ref65" ref-type="bibr">
<sup>65</sup>
</xref><sup>)</sup>. However, one study found that the variation contributed by the
postprandial period on circulating TAG and inflammatory mediators was greater than the
hormonal differences between the follicular and luteal phases<sup>(</sup><xref rid="ref66" ref-type="bibr">
<sup>66</sup>
</xref><sup>)</sup>.</p></sec><sec id="sec4"><title/><sec disp-level="2" id="sec4-1" sec-type="conclusion"><title>Conclusions</title><p>Results from this study provide important information about the specific effects of the
dairy-derived matrix <italic>v</italic>. non-dairy alternative SFA as part of a mixed meal
on a wide array of inflammatory markers in the postprandial state, directly addressing
several key concerns and gaps in knowledge addressed by a recent expert panel. There was
no evidence from this study in overweight and obese adults that there is a difference in
inflammatory response after a high-fat mixed meal where the predominant fat source is
cheese <italic>v</italic>. palm oil. From the inflammatory markers that were measured only
IL-6, IL-8, IL-18, MCP-1, TNF&#x003b1; and SAA showed a postprandial response with respect to
early postprandial cytokine induction, regardless of which treatment was consumed. When
analysed as the iAUC, postprandial CRP was significantly lower in response to the cheese
compared with the vegan test meal. Based on these results we conclude that while dietary
recommendations encourage a decreased consumption of saturated fat to minimise CVD risk,
saturated fat in the form of cheese lowers postprandial inflammation compared with plant
sources of saturated fat.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This project was made possible by support from the National Dairy Council (Rosemont, IL)
and the US Department of Agriculture (USDA), Agricultural Research Service, Western Human
Nutrition Research Center.</p><p>The authors would like to thank the study participants for their time and efforts to comply
with the study requirements. The authors would like to thank: the Western Human Nutrition
Research Center kitchen personnel Dustin Burnett, Sara Dowling and Julie Edwards;
phlebotomist Jerome Crawford; and physiologist Mary Gustafson for their dedication to the
project. The USDA is an equal opportunity employer and provider.</p><p>A. M. Z., J. T. S., J. B. G. and M. D. V. L. designed the research; E. D., N. R., T. S. R.
and E. R. G. conducted the research; E. D. analysed the data; and E. D., A. M. Z., J. T. S.
and M. D. V. L. wrote the paper. E. D. had primary responsibility for final content. All
authors read and approved the final manuscript.</p><p>M. D. V. L., A. M. Z. and J. T. S. have received research funding from the National Dairy
Council; A. M. Z. received a stipend from the National Dairy Council to present a talk at a
symposium in 2013. The founding sponsors had no role in the design of the study; in the
collection, analyses or interpretation of data; in the writing of the manuscript, and in the
decision to publish the results. There are no conflicts of interest.</p></ack><sec sec-type="supplementary-material" id="sec5"><title>Supplementary material</title><supplementary-material content-type="local-data" id="S2048679015000403sup001"><p>For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/jns.2015.40.</p><media xlink:href="S2048679015000403sup.zip" mimetype="application" mime-subtype="zip" orientation="portrait" id="d36e3304" position="anchor"><caption><p>click here to view supplementary material</p></caption></media></supplementary-material></sec><ref-list id="reflist1"><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Burdge</surname><given-names>GC</given-names></name> &#x00026; <name><surname>Calder</surname><given-names>PC</given-names></name> (<year>2005</year>) <article-title>Plasma cytokine response during the
postprandial period: a potential causal process in vascular disease?</article-title>
<source>Br J Nutr</source>
<volume>93</volume>, <fpage>3</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">15705218</pub-id></mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Margioris</surname><given-names>AN</given-names></name> (<year>2009</year>) <article-title>Fatty acids and postprandial
inflammation</article-title>. <source>Curr Opin Clin Nutr Metab Care</source>
<volume>12</volume>, <fpage>129</fpage>&#x02013;<lpage>137</lpage>.<pub-id pub-id-type="pmid">19202384</pub-id></mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Patsch</surname><given-names>JR</given-names></name>, <name><surname>Miesenb&#x000f6;ck</surname><given-names>G</given-names></name>, <name><surname>Hopferwieser</surname><given-names>T</given-names></name>, <etal/> (<year>1992</year>) <article-title>Relation of triglyceride metabolism
and coronary artery disease. Studies in the postprandial state</article-title>.
<source>Arterioscler Thromb</source>
<volume>12</volume>, <fpage>1336</fpage>&#x02013;<lpage>1345</lpage>.<pub-id pub-id-type="pmid">1420093</pub-id></mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Keys</surname><given-names>A</given-names></name>, <name><surname>Anderson</surname><given-names>J</given-names></name> &#x00026; <name><surname>Grande</surname><given-names>F</given-names></name> (<year>1957</year>) <article-title>Prediction of serum-cholesterol responses of
man to changes in fats in the diet</article-title>. <source>Lancet</source>
<volume>i</volume>, <fpage>959</fpage>&#x02013;<lpage>966</lpage>.<pub-id pub-id-type="pmid">13482259</pub-id></mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Kushi</surname><given-names>LH</given-names></name>, <name><surname>Lew</surname><given-names>RA</given-names></name>, <name><surname>Stare</surname><given-names>FJ</given-names></name>, <etal/> (<year>1985</year>) <article-title>Diet and 20-year mortality from
coronary heart disease: the Ireland&#x02013;Boston Diet&#x02013;Heart Study</article-title>. <source>New
Engl J Med</source>
<volume>312</volume>, <fpage>811</fpage>&#x02013;<lpage>818</lpage>.<pub-id pub-id-type="pmid">2983212</pub-id></mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Erkkil&#x000e4;</surname><given-names>A</given-names></name>, <name><surname>de Mello</surname><given-names>VD</given-names></name>, <name><surname>Ris&#x000e9;rus</surname><given-names>U</given-names></name>, <etal/> (<year>2008</year>) <article-title>Dietary fatty acids and cardiovascular
disease: an epidemiological approach</article-title>. <source>Prog Lipid Res</source>
<volume>47</volume>, <fpage>172</fpage>&#x02013;<lpage>187</lpage>.<pub-id pub-id-type="pmid">18328267</pub-id></mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>McGuire</surname><given-names>S</given-names></name> (<year>2011</year>) <article-title>U.S. Department of Agriculture and U.S.
Department of Health and Human Services, Dietary Guidelines for Americans, 2010.
Washington, DC: U.S. Government Printing Office, January 2011</article-title>.
<source>Adv Nutr</source>
<volume>2</volume>, <fpage>293</fpage>&#x02013;<lpage>294</lpage>.<pub-id pub-id-type="pmid">22332062</pub-id></mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Howard</surname><given-names>BV</given-names></name>, <name><surname>Van Horn</surname><given-names>L</given-names></name>, <name><surname>Hsia</surname><given-names>J</given-names></name>, <etal/> (<year>2006</year>) <article-title>Low-fat dietary pattern and risk of
cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary
Modification Trial</article-title>. <source>JAMA</source>
<volume>295</volume>, <fpage>655</fpage>&#x02013;<lpage>666</lpage>.<pub-id pub-id-type="pmid">16467234</pub-id></mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Qin</surname><given-names>L-Q</given-names></name>, <name><surname>Xu</surname><given-names>J-Y</given-names></name>, <name><surname>Han</surname><given-names>S-F</given-names></name>, <etal/> (<year>2015</year>) <article-title>Dairy consumption and risk of
cardiovascular disease: an updated meta-analysis of prospective cohort
studies</article-title>. <source>Asia Pac J Clin Nutr</source>
<volume>24</volume>, <fpage>90</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="pmid">25740747</pub-id></mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Nakamura</surname><given-names>T</given-names></name>, <name><surname>Hirota</surname><given-names>T</given-names></name>, <name><surname>Mizushima</surname><given-names>K</given-names></name>, <etal/> (<year>2013</year>) <article-title>Milk-derived peptides, Val-Pro-Pro and
Ile-Pro-Pro, attenuate atherosclerosis development in apolipoprotein E-deficient mice: a
preliminary study</article-title>. <source>J Med Food</source>
<volume>16</volume>, <fpage>396</fpage>&#x02013;<lpage>403</lpage>.<pub-id pub-id-type="pmid">23631494</pub-id></mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Sjogren</surname><given-names>P</given-names></name>, <name><surname>Rosell</surname><given-names>M</given-names></name>, <name><surname>Skoglund-Andersson</surname><given-names>C</given-names></name>, <etal/> (<year>2004</year>) <article-title>Milk-derived fatty acids are
associated with a more favorable LDL particle size distribution in healthy
men</article-title>. <source>J Nutr</source>
<volume>134</volume>, <fpage>1729</fpage>&#x02013;<lpage>1735</lpage>.<pub-id pub-id-type="pmid">15226461</pub-id></mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Settanni</surname><given-names>L</given-names></name> &#x00026; <name><surname>Moschetti</surname><given-names>G</given-names></name> (<year>2010</year>) <article-title>Non-starter lactic acid bacteria used to
improve cheese quality and provide health benefits</article-title>. <source>Food
Microbiol</source>
<volume>27</volume>, <fpage>691</fpage>&#x02013;<lpage>697</lpage>.<pub-id pub-id-type="pmid">20630311</pub-id></mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Snow</surname><given-names>D</given-names></name>, <name><surname>Ward</surname><given-names>R</given-names></name>, <name><surname>Olsen</surname><given-names>A</given-names></name>, <etal/> (<year>2011</year>) <article-title>Membrane-rich milk fat diet provides
protection against gastrointestinal leakiness in mice treated with
lipopolysaccharide</article-title>. <source>J Dairy Sci</source>
<volume>94</volume>, <fpage>2201</fpage>&#x02013;<lpage>2212</lpage>.<pub-id pub-id-type="pmid">21524510</pub-id></mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Jacobs</surname><given-names>DR</given-names></name>, <name><surname>Gross</surname><given-names>MD</given-names></name> &#x00026; <name><surname>Tapsell</surname><given-names>LC</given-names></name> (<year>2009</year>) <article-title>Food synergy: an operational concept for
understanding nutrition</article-title>. <source>Am J Clin Nutr</source>
<volume>89</volume>, <fpage>1543S</fpage>&#x02013;<lpage>1548S</lpage>.<pub-id pub-id-type="pmid">19279083</pub-id></mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Poppitt</surname><given-names>SD</given-names></name>, <name><surname>Keogh</surname><given-names>GF</given-names></name>, <name><surname>Lithander</surname><given-names>FE</given-names></name>, <etal/> (<year>2008</year>) <article-title>Postprandial response of adiponectin,
interleukin-6, tumor necrosis factor-&#x003b1;, and C-reactive protein to a high-fat dietary
load</article-title>. <source>Nutrition</source>
<volume>24</volume>, <fpage>322</fpage>&#x02013;<lpage>329</lpage>.<pub-id pub-id-type="pmid">18262390</pub-id></mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Masson</surname><given-names>CJ</given-names></name> &#x00026; <name><surname>Mensink</surname><given-names>RP</given-names></name> (<year>2011</year>) <article-title>Exchanging saturated fatty acids for
(<italic>n</italic>-6) polyunsaturated fatty acids in a mixed meal may decrease
postprandial lipemia and markers of inflammation and endothelial activity in overweight
men</article-title>. <source>J Nutr</source>
<volume>141</volume>, <fpage>816</fpage>&#x02013;<lpage>821</lpage>.<pub-id pub-id-type="pmid">21430255</pub-id></mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="other"><collab>National Cancer
Institute</collab> (<year>2014</year>) Sources of Saturated Fat, Stearic Acid, &#x00026;
Cholesterol Raising Fat among the US Population, 2005&#x02013;06. Applied Research Program
website, 2014. <uri xlink:type="simple" xlink:href="http://appliedresearch.cancer.gov/diet/foodsources/sat_fat/">http://appliedresearch.cancer.gov/diet/foodsources/sat_fat/</uri>
(accessed <date-in-citation content-type="access-date">November
2015</date-in-citation>).</mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="other"><name><surname>Casalena</surname><given-names>N</given-names></name> (<year>2011</year>) How many Adults are Vegan in the U.S.? Vegetarian Resource
Group. <uri xlink:type="simple" xlink:href="http://www.vrg.org/blog/2011/12/05/how-many-adults-are-vegan-in-the-u-s/">http://www.vrg.org/blog/2011/12/05/how-many-adults-are-vegan-in-the-u-s/</uri>
(accessed <date-in-citation content-type="access-date">January
2016</date-in-citation>).</mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="book"><collab>Dietary Guidelines
Advisory Committee</collab> (<year>2015</year>) <source>Scientific Report of the 2015
Dietary Guidelines Advisory Committee</source>. <publisher-loc>Washington,
DC</publisher-loc>: <publisher-name>USDA and US Department of Health and Human
Services</publisher-name>.</mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Craig</surname><given-names>WJ</given-names></name> &#x00026; <name><surname>Mangels</surname><given-names>AR</given-names></name> (<year>2009</year>) <article-title>Position of the American Dietetic Association:
vegetarian diets</article-title>. <source>J Am Diet Assoc</source>
<volume>109</volume>, <fpage>1266</fpage>&#x02013;<lpage>1282</lpage>.<pub-id pub-id-type="pmid">19562864</pub-id></mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Laugerette</surname><given-names>F</given-names></name>, <name><surname>Furet</surname><given-names>J-P</given-names></name>, <name><surname>Debard</surname><given-names>C</given-names></name>, <etal/> (<year>2012</year>) <article-title>Oil composition of high-fat diet
affects metabolic inflammation differently in connection with endotoxin receptors in
mice</article-title>. <source>Am J Physiol Endocrinol Metab</source>
<volume>302</volume>, <fpage>E374</fpage>&#x02013;<lpage>EE86</lpage>.<pub-id pub-id-type="pmid">22094473</pub-id></mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Grundy</surname><given-names>SM</given-names></name>, <name><surname>Cleeman</surname><given-names>JI</given-names></name>, <name><surname>Daniels</surname><given-names>SR</given-names></name>, <etal/> (<year>2005</year>) <article-title>Diagnosis and management of the
metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood
Institute scientific statement</article-title>. <source>Circulation</source>
<volume>112</volume>, <fpage>2735</fpage>&#x02013;<lpage>2752</lpage>.<pub-id pub-id-type="pmid">16157765</pub-id></mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Ascaso</surname><given-names>JF</given-names></name>, <name><surname>Pardo</surname><given-names>S</given-names></name>, <name><surname>Real</surname><given-names>JT</given-names></name>, <etal/> (<year>2003</year>) <article-title>Diagnosing insulin resistance by
simple quantitative methods in subjects with normal glucose metabolism</article-title>.
<source>Diabetes Care</source>
<volume>26</volume>, <fpage>3320</fpage>&#x02013;<lpage>3325</lpage>.<pub-id pub-id-type="pmid">14633821</pub-id></mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Pearson</surname><given-names>TA</given-names></name>, <name><surname>Mensah</surname><given-names>GA</given-names></name>, <name><surname>Alexander</surname><given-names>RW</given-names></name>, <etal/> (<year>2003</year>) <article-title>Markers of inflammation and
cardiovascular disease: application to clinical and public health practice: a statement
for healthcare professionals from the Centers for Disease Control and Prevention and the
American Heart Association</article-title>. <source>Circulation</source>
<volume>107</volume>, <fpage>499&#x02013;511</fpage>.<pub-id pub-id-type="pmid">12551878</pub-id></mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Pedersen</surname><given-names>A</given-names></name>, <name><surname>Sandstr&#x000f6;m</surname><given-names>B</given-names></name> &#x00026; <name><surname>Van Amelsvoort</surname><given-names>JMM</given-names></name> (<year>1997</year>) <article-title>The effect of ingestion of inulin on blood
lipids and gastrointestinal symptoms in healthy females</article-title>. <source>Br J
Nutr</source>
<volume>78</volume>, <fpage>215</fpage>&#x02013;<lpage>222</lpage>.<pub-id pub-id-type="pmid">9301412</pub-id></mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Gouveia-Figueira</surname><given-names>S</given-names></name>, <name><surname>Sp&#x000e4;th</surname><given-names>J</given-names></name>, <name><surname>Zivkovic</surname><given-names>AM</given-names></name>, <etal/> (<year>2015</year>) <article-title>Profiling the oxylipin and
endocannabinoid metabolome by UPLC-ESI-MS/MS in human plasma to monitor postprandial
inflammation</article-title>. <source>PLOS ONE</source>
<volume>10</volume>, <elocation-id>e9</elocation-id>.</mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Zivkovic</surname><given-names>AM</given-names></name>, <name><surname>Telis</surname><given-names>N</given-names></name>, <name><surname>German</surname><given-names>JB</given-names></name>, <etal/> (<year>2011</year>) <article-title>Dietary omega-3 fatty acids aid in the
modulation of inflammation and metabolic health</article-title>. <source>Calif Agric
(Berkeley)</source>
<volume>65</volume>, <fpage>106</fpage>&#x02013;<lpage>111</lpage>.<pub-id pub-id-type="pmid">24860193</pub-id></mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Trumbo</surname><given-names>P</given-names></name>, <name><surname>Schlicker</surname><given-names>S</given-names></name>, <name><surname>Yates</surname><given-names>A</given-names></name>, <etal/> (<year>2002</year>) <article-title>Dietary reference intakes for energy,
carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino
acids</article-title>. <source>J Am Diet Assoc</source>
<volume>102</volume>, <fpage>1621</fpage>&#x02013;<lpage>1630</lpage>.<pub-id pub-id-type="pmid">12449285</pub-id></mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Baecke</surname><given-names>J</given-names></name>, <name><surname>Burema</surname><given-names>J</given-names></name> &#x00026; <name><surname>Frijters</surname><given-names>J</given-names></name> (<year>1982</year>) <article-title>A short questionnaire for the measurement of
habitual physical activity in epidemiological studies</article-title>. <source>Am J Clin
Nutr</source>
<volume>36</volume>, <fpage>936</fpage>&#x02013;<lpage>942</lpage>.<pub-id pub-id-type="pmid">7137077</pub-id></mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Herieka</surname><given-names>M</given-names></name> &#x00026; <name><surname>Erridge</surname><given-names>C</given-names></name> (<year>2014</year>) <article-title>High-fat meal induced postprandial
inflammation</article-title>. <source>Mol NutrFood Res</source>
<volume>58</volume>, <fpage>136</fpage>&#x02013;<lpage>146</lpage>.</mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Perez-Martinez</surname><given-names>P</given-names></name>, <name><surname>Alcala-Diaz</surname><given-names>JF</given-names></name>, <name><surname>Delgado-Lista</surname><given-names>J</given-names></name>, <etal/> (<year>2014</year>) <article-title>Metabolic phenotypes of obesity
influence triglyceride and inflammation homoeostasis</article-title>. <source>Eur J Clin
Invest</source>
<volume>44</volume>, <fpage>1053</fpage>&#x02013;<lpage>1064</lpage>.<pub-id pub-id-type="pmid">25231836</pub-id></mixed-citation></ref><ref id="ref32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Carstensen</surname><given-names>M</given-names></name>, <name><surname>Thomsen</surname><given-names>C</given-names></name> &#x00026; <name><surname>Hermansen</surname><given-names>K</given-names></name> (<year>2003</year>) <article-title>Incremental area under response curve more
accurately describes the triglyceride response to an oral fat load in both healthy and
type 2 diabetic subjects</article-title>. <source>Metabolism</source>
<volume>52</volume>, <fpage>1034</fpage>&#x02013;<lpage>1037</lpage>.<pub-id pub-id-type="pmid">12898469</pub-id></mixed-citation></ref><ref id="ref33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Kleiner</surname><given-names>G</given-names></name>, <name><surname>Marcuzzi</surname><given-names>A</given-names></name>, <name><surname>Zanin</surname><given-names>V</given-names></name>, <etal/> (<year>2013</year>) <article-title>Cytokine levels in the serum of
healthy subjects</article-title>. <source>Mediators Inflamm</source>
<volume>2013</volume>, 434010.</mixed-citation></ref><ref id="ref34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Tulk</surname><given-names>HM</given-names></name> &#x00026; <name><surname>Robinson</surname><given-names>LE</given-names></name> (<year>2009</year>) <article-title>Modifying the
<italic>n</italic>-6/<italic>n</italic>-3 polyunsaturated fatty acid ratio of a
high-saturated fat challenge does not acutely attenuate postprandial changes in
inflammatory markers in men with metabolic syndrome</article-title>. <source>Metabolism</source>
<volume>58</volume>, <fpage>1709</fpage>&#x02013;<lpage>1716</lpage>.<pub-id pub-id-type="pmid">19625064</pub-id></mixed-citation></ref><ref id="ref35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Blackburn</surname><given-names>P</given-names></name>, <name><surname>Despr&#x000e9;s</surname><given-names>JP</given-names></name>, <name><surname>Lamarche</surname><given-names>B</given-names></name>, <etal/> (<year>2006</year>) <article-title>Postprandial variations of plasma
inflammatory markers in abdominally obese men</article-title>. <source>Obesity</source>
<volume>14</volume>, <fpage>1747</fpage>&#x02013;<lpage>1754</lpage>.<pub-id pub-id-type="pmid">17062804</pub-id></mixed-citation></ref><ref id="ref36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Manning</surname><given-names>PJ</given-names></name>, <name><surname>Sutherland</surname><given-names>WHF</given-names></name>, <name><surname>McGrath</surname><given-names>MM</given-names></name>, <etal/> (<year>2008</year>) <article-title>Postprandial cytokine concentrations
and meal composition in obese and lean women</article-title>. <source>Obesity</source>
<volume>16</volume>, <fpage>2046</fpage>&#x02013;<lpage>2052</lpage>.<pub-id pub-id-type="pmid">19186329</pub-id></mixed-citation></ref><ref id="ref37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>van Oostrom</surname><given-names>AJHHM</given-names></name>, <name><surname>Sijmonsma</surname><given-names>TP</given-names></name>, <name><surname>Verseyden</surname><given-names>C</given-names></name>, <etal/> (<year>2003</year>) <article-title>Postprandial recruitment of
neutrophils may contribute to endothelial dysfunction</article-title>. <source>J Lipid
Res</source>
<volume>44</volume>, <fpage>576</fpage>&#x02013;<lpage>583</lpage>.<pub-id pub-id-type="pmid">12562833</pub-id></mixed-citation></ref><ref id="ref38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>Nappo</surname><given-names>F</given-names></name>, <name><surname>Esposito</surname><given-names>K</given-names></name>, <name><surname>Cioffi</surname><given-names>M</given-names></name>, <etal/> (<year>2002</year>) <article-title>Postprandial endothelial activation in
healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate
meals</article-title>. <source>J Am Coll Cardiol</source>
<volume>39</volume>, <fpage>1145</fpage>&#x02013;<lpage>1150</lpage>.<pub-id pub-id-type="pmid">11923038</pub-id></mixed-citation></ref><ref id="ref39"><label>39.</label><mixed-citation publication-type="journal"><name><surname>Dandona</surname><given-names>P</given-names></name>, <name><surname>Aljada</surname><given-names>A</given-names></name>, <name><surname>Mohanty</surname><given-names>P</given-names></name>, <etal/> (<year>2001</year>) <article-title>Insulin inhibits intranuclear nuclear
factor &#x003ba;B and stimulates I&#x003ba;B in mononuclear cells in obese subjects: evidence for an
anti-inflammatory effect?</article-title>
<source>J Clin Endocrinol Metab</source>
<volume>86</volume>, <fpage>3257</fpage>&#x02013;<lpage>3265</lpage>.<pub-id pub-id-type="pmid">11443198</pub-id></mixed-citation></ref><ref id="ref40"><label>40.</label><mixed-citation publication-type="journal"><name><surname>Baggiolini</surname><given-names>M</given-names></name>, <name><surname>Moser</surname><given-names>B</given-names></name> &#x00026; <name><surname>Clark-Lewis</surname><given-names>I</given-names></name> (<year>1994</year>) <article-title>Interleukin-8 and related chemotactic
cytokines: the Giles Filley lecture</article-title>. <source>Chest</source>
<volume>105</volume>, <issue>3 Suppl.</issue>,
<fpage>95S</fpage>&#x02013;<lpage>98S</lpage>.<pub-id pub-id-type="pmid">8131628</pub-id></mixed-citation></ref><ref id="ref41"><label>41.</label><mixed-citation publication-type="journal"><name><surname>Mallat</surname><given-names>Z</given-names></name>, <name><surname>Heymes</surname><given-names>C</given-names></name>, <name><surname>Corbaz</surname><given-names>A</given-names></name>, <etal/> (<year>2004</year>) <article-title>Evidence for altered interleukin 18
(IL)-18 pathway in human heart failure</article-title>. <source>FASEB J</source>
<volume>18</volume>, <fpage>1752</fpage>&#x02013;<lpage>1754</lpage>.<pub-id pub-id-type="pmid">15371332</pub-id></mixed-citation></ref><ref id="ref42"><label>42.</label><mixed-citation publication-type="journal"><name><surname>Hyson</surname><given-names>DA</given-names></name>, <name><surname>Paglieroni</surname><given-names>TG</given-names></name>, <name><surname>Wun</surname><given-names>T</given-names></name>, <etal/> (<year>2002</year>) <article-title>Postprandial lipemia is associated
with platelet and monocyte activation and increased monocyte cytokine expression in
normolipemic men</article-title>. <source>Clin Appl Thromb Hemost</source>
<volume>8</volume>, <fpage>147</fpage>&#x02013;<lpage>155</lpage>.<pub-id pub-id-type="pmid">12121056</pub-id></mixed-citation></ref><ref id="ref43"><label>43.</label><mixed-citation publication-type="journal"><name><surname>Rosenson</surname><given-names>RS</given-names></name>, <name><surname>Huskin</surname><given-names>AL</given-names></name>, <name><surname>Wolff</surname><given-names>DA</given-names></name>, <etal/> (<year>2008</year>) <article-title>Fenofibrate reduces fasting and
postprandial inflammatory responses among hypertriglyceridemia patients with the
metabolic syndrome</article-title>. <source>Atherosclerosis</source>
<volume>198</volume>, <fpage>381</fpage>&#x02013;<lpage>388</lpage>.<pub-id pub-id-type="pmid">18242616</pub-id></mixed-citation></ref><ref id="ref44"><label>44.</label><mixed-citation publication-type="journal"><name><surname>Pepys</surname><given-names>M</given-names></name> &#x00026; <name><surname>Baltz</surname><given-names>ML</given-names></name> (<year>1982</year>) <article-title>Acute phase proteins with special reference to
C-reactive protein and related proteins (pentaxins) and serum amyloid A
protein</article-title>. <source>Adv Immunol</source>
<volume>34</volume>, <fpage>141</fpage>&#x02013;<lpage>212</lpage>.<pub-id pub-id-type="pmid">6356809</pub-id></mixed-citation></ref><ref id="ref45"><label>45.</label><mixed-citation publication-type="journal"><name><surname>Hagihara</surname><given-names>K</given-names></name>, <name><surname>Nishikawa</surname><given-names>T</given-names></name>, <name><surname>Isobe</surname><given-names>T</given-names></name>, <etal/> (<year>2004</year>) <article-title>IL-6 plays a critical role in the
synergistic induction of human serum amyloid A (SAA) gene when stimulated with
proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR
assay system</article-title>. <source>Biochem Biophys Res Comm</source>
<volume>314</volume>, <fpage>363</fpage>&#x02013;<lpage>369</lpage>.<pub-id pub-id-type="pmid">14733913</pub-id></mixed-citation></ref><ref id="ref46"><label>46.</label><mixed-citation publication-type="journal"><name><surname>O'Reilly</surname><given-names>S</given-names></name>, <name><surname>Cant</surname><given-names>R</given-names></name>, <name><surname>Ciechomska</surname><given-names>M</given-names></name>, <etal/> (<year>2014</year>) <article-title>Serum amyloid A induces interleukin-6
in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase
4 and nuclear factor-&#x003ba;B</article-title>. <source>Immunology</source>
<volume>143</volume>, <fpage>331</fpage>&#x02013;<lpage>340</lpage>.<pub-id pub-id-type="pmid">24476318</pub-id></mixed-citation></ref><ref id="ref47"><label>47.</label><mixed-citation publication-type="journal"><name><surname>O'Brien</surname><given-names>KD</given-names></name> &#x00026; <name><surname>Chait</surname><given-names>A</given-names></name> (<year>2006</year>) <article-title>Serum amyloid A: the &#x0201c;other&#x0201d; inflammatory
protein</article-title>. <source>Curr Ather Rep</source>
<volume>8</volume>, <fpage>62</fpage>&#x02013;<lpage>68</lpage>.</mixed-citation></ref><ref id="ref48"><label>48.</label><mixed-citation publication-type="journal"><name><surname>Esser</surname><given-names>D</given-names></name>, <name><surname>Oosterink</surname><given-names>E</given-names></name>, <name><surname>op't Roodt</surname><given-names>J</given-names></name>, <etal/> (<year>2013</year>) <article-title>Vascular and inflammatory high fat
meal responses in young healthy men; a discriminative role of IL-8 observed in a
randomized trial</article-title>. <source>PLOS ONE</source>
<volume>8</volume>, <elocation-id>e9</elocation-id>.</mixed-citation></ref><ref id="ref49"><label>49.</label><mixed-citation publication-type="journal"><name><surname>Schmid</surname><given-names>A</given-names></name>, <name><surname>Petry</surname><given-names>N</given-names></name>, <name><surname>Walther</surname><given-names>B</given-names></name>, <etal/> (<year>2015</year>) <article-title>Inflammatory and metabolic responses
to high-fat meals with and without dairy products in men</article-title>. <source>Br J
Nutr</source>
<volume>113</volume>, <fpage>1853</fpage>&#x02013;<lpage>1861</lpage>.<pub-id pub-id-type="pmid">25990454</pub-id></mixed-citation></ref><ref id="ref50"><label>50.</label><mixed-citation publication-type="journal"><name><surname>Ajani</surname><given-names>UA</given-names></name>, <name><surname>Ford</surname><given-names>ES</given-names></name> &#x00026; <name><surname>Mokdad</surname><given-names>AH</given-names></name> (<year>2004</year>) <article-title>Dietary fiber and C-reactive protein: findings
from National Health and Nutrition Examination Survey data</article-title>. <source>J
Nutr</source>
<volume>134</volume>, <fpage>1181</fpage>&#x02013;<lpage>1185</lpage>.<pub-id pub-id-type="pmid">15113967</pub-id></mixed-citation></ref><ref id="ref51"><label>51.</label><mixed-citation publication-type="journal"><name><surname>Milani</surname><given-names>RV</given-names></name>, <name><surname>Lavie</surname><given-names>CJ</given-names></name> &#x00026; <name><surname>Mehra</surname><given-names>MR</given-names></name> (<year>2004</year>) <article-title>Reduction in C-reactive protein through cardiac
rehabilitation and exercise training</article-title>. <source>J Am Coll Cardiol</source>
<volume>43</volume>, <fpage>1056</fpage>&#x02013;<lpage>1061</lpage>.<pub-id pub-id-type="pmid">15028366</pub-id></mixed-citation></ref><ref id="ref52"><label>52.</label><mixed-citation publication-type="journal"><name><surname>Hackam</surname><given-names>DG</given-names></name> &#x00026; <name><surname>Anand</surname><given-names>SS</given-names></name> (<year>2003</year>) <article-title>Emerging risk factors for atherosclerotic
vascular disease: a critical review of the evidence</article-title>. <source>JAMA</source>
<volume>290</volume>, <fpage>932</fpage>&#x02013;<lpage>940</lpage>.<pub-id pub-id-type="pmid">12928471</pub-id></mixed-citation></ref><ref id="ref53"><label>53.</label><mixed-citation publication-type="journal"><name><surname>Carroll</surname><given-names>MF</given-names></name>, <name><surname>Schade</surname><given-names>DS</given-names></name> (<year>2003</year>) <article-title>Timing of antioxidant vitamin ingestion alters
postprandial proatherogenic serum markers</article-title>. <source>Circulation</source>
<volume>108</volume>, <fpage>24</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">12821556</pub-id></mixed-citation></ref><ref id="ref54"><label>54.</label><mixed-citation publication-type="journal"><name><surname>Ceriello</surname><given-names>A</given-names></name>, <name><surname>Assaloni</surname><given-names>R</given-names></name>, <name><surname>Da Ros</surname><given-names>R</given-names></name>, <etal/> (<year>2005</year>) <article-title>Effect of atorvastatin and irbesartan,
alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and
inflammation in type 2 diabetic patients</article-title>. <source>Circulation</source>
<volume>111</volume>, <fpage>2518</fpage>&#x02013;<lpage>2524</lpage>.<pub-id pub-id-type="pmid">15867169</pub-id></mixed-citation></ref><ref id="ref55"><label>55.</label><mixed-citation publication-type="journal"><name><surname>Nakamura</surname><given-names>A</given-names></name>, <name><surname>Monma</surname><given-names>Y</given-names></name>, <name><surname>Kajitani</surname><given-names>S</given-names></name>, <etal/> (<year>2015</year>) <article-title>Effect of glycemic state on
postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery
disease</article-title>. <source>Heart Vessels</source>
<volume>2015</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="ref56"><label>56.</label><mixed-citation publication-type="journal"><name><surname>Panagiotakos</surname><given-names>DB</given-names></name>, <name><surname>Pitsavos</surname><given-names>CH</given-names></name>, <name><surname>Zampelas</surname><given-names>AD</given-names></name>, <etal/> (<year>2010</year>) <article-title>Dairy products consumption is
associated with decreased levels of inflammatory markers related to cardiovascular
disease in apparently healthy adults: The ATTICA Study</article-title>. <source>J Am
Coll Nutr</source>
<volume>29</volume>, <fpage>357</fpage>&#x02013;<lpage>364</lpage>.<pub-id pub-id-type="pmid">21041810</pub-id></mixed-citation></ref><ref id="ref57"><label>57.</label><mixed-citation publication-type="journal"><name><surname>Baldi</surname><given-names>A</given-names></name>, <name><surname>Ioannis</surname><given-names>P</given-names></name>, <name><surname>Chiara</surname><given-names>P</given-names></name>, <etal/> (<year>2005</year>) <article-title>Biological effects of milk proteins
and their peptides with emphasis on those related to the gastrointestinal
ecosystem</article-title>. <source>J Dairy Res</source>
<volume>72,</volume> Special no., <fpage>66</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">16180723</pub-id></mixed-citation></ref><ref id="ref58"><label>58.</label><mixed-citation publication-type="journal"><name><surname>Harsha</surname><given-names>WT</given-names></name>, <name><surname>Kalandarova</surname><given-names>E</given-names></name>, <name><surname>McNutt</surname><given-names>P</given-names></name>, <etal/> (<year>2006</year>) <article-title>Nutritional supplementation with
transforming growth factor-&#x003b2;, glutamine, and short chain fatty acids minimizes
methotrexate-induced injury</article-title>. <source>J Pediatr Gastroenterol Nutr</source>
<volume>42</volume>, <fpage>53</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="pmid">16385254</pub-id></mixed-citation></ref><ref id="ref59"><label>59.</label><mixed-citation publication-type="journal"><name><surname>Gopal</surname><given-names>PK</given-names></name> &#x00026; <name><surname>Gill</surname><given-names>H</given-names></name> (<year>2000</year>) <article-title>Oligosaccharides and glycoconjugates in bovine
milk and colostrum</article-title>. <source>Br J Nutr</source>
<volume>84,</volume>
<issue>Suppl. 1</issue>, <fpage>69</fpage>&#x02013;<lpage>74</lpage>.</mixed-citation></ref><ref id="ref60"><label>60.</label><mixed-citation publication-type="journal"><name><surname>Despr&#x000e9;s</surname><given-names>J-P</given-names></name> &#x00026; <name><surname>Lemieux</surname><given-names>I</given-names></name> (<year>2006</year>) <article-title>Abdominal obesity and metabolic
syndrome</article-title>. <source>Nature</source>
<volume>444</volume>, <fpage>881</fpage>&#x02013;<lpage>887</lpage>.<pub-id pub-id-type="pmid">17167477</pub-id></mixed-citation></ref><ref id="ref61"><label>61.</label><mixed-citation publication-type="journal"><name><surname>Agorastos</surname><given-names>A</given-names></name>, <name><surname>Hauger</surname><given-names>RL</given-names></name>, <name><surname>Barkauskas</surname><given-names>DA</given-names></name>, <etal/> (<year>2014</year>) <article-title>Circadian rhythmicity, variability and
correlation of interleukin-6 levels in plasma and cerebrospinal fluid of healthy
men</article-title>. <source>Psychoneuroendocrinology</source>
<volume>44</volume>, <fpage>71</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">24767621</pub-id></mixed-citation></ref><ref id="ref62"><label>62.</label><mixed-citation publication-type="journal"><name><surname>Soerensen</surname><given-names>KV</given-names></name>, <name><surname>Thorning</surname><given-names>TK</given-names></name>, <name><surname>Astrup</surname><given-names>A</given-names></name>, <etal/> (<year>2014</year>) <article-title>Effect of dairy calcium from cheese
and milk on fecal fat excretion, blood lipids, and appetite in young
men</article-title>. <source>Am J Clin Nutr</source>
<volume>99</volume>, <fpage>984</fpage>&#x02013;<lpage>991</lpage>.<pub-id pub-id-type="pmid">24622806</pub-id></mixed-citation></ref><ref id="ref63"><label>63.</label><mixed-citation publication-type="journal"><name><surname>Hjerpsted</surname><given-names>J</given-names></name>, <name><surname>Leedo</surname><given-names>E</given-names></name> &#x00026; <name><surname>Tholstrup</surname><given-names>T</given-names></name> (<year>2011</year>) <article-title>Cheese intake in large amounts lowers
LDL-cholesterol concentrations compared with butter intake of equal fat
content</article-title>. <source>Am J Clin Nutr</source>
<volume>94</volume>, <fpage>1479</fpage>&#x02013;<lpage>1484</lpage>.<pub-id pub-id-type="pmid">22030228</pub-id></mixed-citation></ref><ref id="ref64"><label>64.</label><mixed-citation publication-type="journal"><name><surname>Payette</surname><given-names>C</given-names></name>, <name><surname>Blackburn</surname><given-names>P</given-names></name>, <name><surname>Lamarche</surname><given-names>B</given-names></name>, <etal/> (<year>2009</year>) <article-title>Sex differences in postprandial plasma
tumor necrosis factor-&#x003b1;, interleukin-6, and C-reactive protein
concentrations</article-title>. <source>Metabolism</source>
<volume>58</volume>, <fpage>1593</fpage>&#x02013;<lpage>1601</lpage>.<pub-id pub-id-type="pmid">19604525</pub-id></mixed-citation></ref><ref id="ref65"><label>65.</label><mixed-citation publication-type="journal"><name><surname>Barnett</surname><given-names>JB</given-names></name>, <name><surname>Woods</surname><given-names>MN</given-names></name>, <name><surname>Lamon-Fava</surname><given-names>S</given-names></name>, <etal/> (<year>2004</year>) <article-title>Plasma lipid and lipoprotein levels
during the follicular and luteal phases of the menstrual cycle</article-title>.
<source>J Clin Endocrinol Metab</source>
<volume>89</volume>, <fpage>776</fpage>&#x02013;<lpage>782</lpage>.<pub-id pub-id-type="pmid">14764796</pub-id></mixed-citation></ref><ref id="ref66"><label>66.</label><mixed-citation publication-type="journal"><name><surname>Bell</surname><given-names>HK</given-names></name> &#x00026; <name><surname>Bloomer</surname><given-names>RJ</given-names></name> (<year>2010</year>) <article-title>Impact of serum estradiol on postprandial
lipemia, oxidative stress, and inflammation across a single menstrual
cycle</article-title>. <source>Gend Med</source>
<volume>7</volume>, <fpage>166</fpage>&#x02013;<lpage>178</lpage>.<pub-id pub-id-type="pmid">20435279</pub-id></mixed-citation></ref></ref-list></back></article>